François Bertucci

Publications

Article dans une revue (423)

Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti–PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer Stéphane Fattori,Laurent Gorvel,Marie-Sarah Rouviére,Samuel Granjeaud,Amira Ben Amaraet al. Cancer Immunology Research, 2025, 13 (10), pp.1623-1639. ⟨10.1158/2326-6066.CIR-24-1285⟩ Article dans une revue hal-05555456v1
Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity Chaïma Cherif,Dang Tan Nguyen,Clément Paris,Thi Khanh Le,Thibaud Sefianeet al. Oncogene, 2025, 44 (45), pp.4440-4440. ⟨10.1038/s41388-025-03614-7⟩ Article dans une revue hal-05578045v1
Dasatinib overcomes AML cells resistant to BCL2 inhibition by degrading MCL1 Sylvain Garciaz,Camille Montersino,Maxence Bourgoin,Arnaud Jacquel,Rémy Castellanoet al. British Journal of Haematology, 2025, 207 (2), pp.381-386. ⟨10.1111/bjh.20195⟩ Article dans une revue hal-05575967v1
The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage Georgios Efthymiou,Eugénie Lohmann,Claudio Montenegro,Paraskevi Kousteridou,Pierre Bertrandet al. Science Advances , 2025, 11 (50), ⟨10.1126/sciadv.adu2276⟩ Article dans une revue hal-05575929v1
Clinical presentation, management and outcome of 11132 patients with liposarcoma: a population-based study from the NETSARC+ registry Jean-Yves Blay,Maud Toulmonde,Thibaud Valentin,Nelly Firmin,Sarah Watsonet al. The Lancet Regional Health - Europe, 2025, 57, ⟨10.1016/j.lanepe.2025.101403⟩ Article dans une revue hal-05305292v1
DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer Thi Khanh Le,Chaïma Cherif,Kenneth Omabe,Clément Paris,François Lanneset al. Molecular Therapy, 2025, 33 (10), pp.5282. ⟨10.1016/j.ymthe.2025.08.041⟩ Article dans une revue hal-05470210v1
Expression of antibody–drug conjugate targets in soft tissue sarcomas François Bertucci,P. Finetti,L. Mescam,A. Monneur,A. Frejafonet al. ESMO Open, 2025, 10 (10), pp.105837. ⟨10.1016/j.esmoop.2025.105837⟩ Article dans une revue hal-05489959v1
Gene expression-based rationale for investigating CDK4/6 inhibitors in primitive myelofibrosis Anne Murati,Pascal Finetti,Estelle Duprez,Jérôme Rey,Emilie Mamessieret al. Leukemia, 2025, 39, pp.2299-2301. ⟨10.1038/s41375-025-02669-5⟩ Article dans une revue hal-05147704v1
Toxicity Profiles of Antibody–Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer Bérénice Collineau,Anthony Gonçalves,Marie Domon,Damien Bruyat,François Bertucciet al. Cancers, 2025, 17 (14), pp.2307. ⟨10.3390/cancers17142307⟩ Article dans une revue hal-05578046v1
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC database Emmanuelle Bompas,Loic Campion,Maud Toulmonde,Axel Le Cesne,Mélanie Saint-Jeanet al. European Journal of Cancer, 2025, 229, pp.115788. ⟨10.1016/j.ejca.2025.115788⟩ Article dans une revue hal-05305479v1
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand? Arthur Géraud,Paul Gougis,Alexandre de Nonneville,Mathilde Beaufils,François Bertucciet al. Cancer Treatment Reviews, 2025, 135, pp.102922. ⟨10.1016/j.ctrv.2025.102922⟩ Article dans une revue hal-05240065v1
The plasma nanoDSF denaturation profiles predict the presence of breast cancer Mathilde Guerin,Rémi Eyraud,Philippe Tsvetkov,Pascal Finetti,Alexandre Giraudoet al. Journal of Translational Medicine, 2025, ⟨10.1186/s12967-025-07499-8⟩ Article dans une revue hal-05489996v1
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization Lan Phi,Yating Cheng,Yohei Funakoshi,Francois Bertucci,Pascal Finettiet al. Breast Cancer Research, 2025, 27 (1), pp.70. ⟨10.1186/s13058-025-02015-8⟩ Article dans une revue hal-05578729v1
ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors Marc Lopez,Emerence Crompot,Emmanuelle Josselin,Anne Farina,Marion Rubiset al. Cancer Research Communications, 2024, 4 (11), pp.2998-3012. ⟨10.1158/2767-9764.CRC-24-0176⟩ Article dans une revue hal-04887527v1
Deciphering Folate Receptor alphaGene Expression and mRNA Signatures in Ovarian Cancer: Implications for Precision Therapies Maria Kfoury,Pascal Finetti,Emilie Mamessier,François Bertucci,Renaud Sabatier International Journal of Molecular Sciences, 2024, 25 (22), pp.11953. ⟨10.3390/ijms252211953⟩ Article dans une revue hal-04945209v1
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent Justine Gantzer,Maud Toulmonde,François Séverac,Ali N. Chamseddine,Celine Charon-Barraet al. Cancer, 2024, 130 (13), pp.2304-2314. ⟨10.1002/cncr.35277⟩ Article dans une revue hal-04533834v1
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant Christophe van Berckelaer,Steven van Laere,Seayoung Lee,Michael Morse,Joseph Geradtset al. Translational Oncology, 2024, 43, pp.101907. ⟨10.1016/j.tranon.2024.101907⟩ Article dans une revue hal-05141638v1
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials Xavier Choderlos de Laclos,Séverine Risbourg,Bernadette Brennan,François Bertucci,Nathalie Gasparet al. European Journal of Cancer, 2024, 208, pp.114229-114229. ⟨10.1016/j.ejca.2024.114229⟩ Article dans une revue hal-04894031v1
Altered ribosomal profile in acquired resistance and reversal associates with pathological response to chemotherapy in inflammatory breast cancer Gayathri Devi,Pritha Pai,Seayoung Lee,Matthew Foster,Dorababu Sannareddyet al. npj Breast Cancer, 2024, 10 (1), pp.65. ⟨10.1038/s41523-024-00664-0⟩ Article dans une revue hal-05141614v1
Synthèse des profils de toxicité des anticorps drogue-conjugués dans le cancer du sein Bérénice Collineau,Anthony Gonçalves,François Bertucci,Alexandre de Nonneville Bulletin du Cancer, 2024, 111 (7-8), pp.765-781. ⟨10.1016/j.bulcan.2024.04.004⟩ Article dans une revue hal-05141544v1
Mutational landscape of inflammatory breast cancer François Bertucci,Florence Lerebours,Michele Ceccarelli,Arnaud Guille,Najeeb Syedet al. Journal of Translational Medicine, 2024, 22 (1), pp.374. ⟨10.1186/s12967-024-05198-4⟩ Article dans une revue hal-04945227v1
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization Alexandre de Nonneville,Elsa Kalbacher,Francesco Cannone,Arnaud Guille,José Adelaïdeet al. Molecular Oncology, 2024, ⟨10.1002/1878-0261.13679⟩ Article dans une revue hal-04933229v1
The co-expression of antigen targets as a rationale for ADC combination in urothelial cancer F. Bertucci,A. de Nonneville,P. Finetti,A. Cohendet,A. Guilleet al. Annals of Oncology, 2024, 35 (5), pp.477-478. ⟨10.1016/j.annonc.2024.02.001⟩ Article dans une revue hal-04932857v1
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy François Bertucci,Arnaud Guille,Florence Lerebours,Michele Ceccarelli,Najeeb Syedet al. Journal of Translational Medicine, 2024, 22 (1), pp.969. ⟨10.1186/s12967-024-05790-8⟩ Article dans une revue hal-04933187v1
Prognostic and Predictive Value of LIV1 Expression in Early Breast Cancer and by Molecular Subtype Alexandre de Nonneville,Pascal Finetti,Laurys Boudin,Emilie Denicolaï,Daniel Birnbaumet al. Pharmaceutics, 2023, 15 (3), pp.938. ⟨10.3390/pharmaceutics15030938⟩ Article dans une revue hal-04390874v1
PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma David Jeremie Birnbaum,Maelle Picard,Quentin da Costa,Thomas Delayre,Pascal Finettiet al. Cancers, 2023, 15 (2), pp.447. ⟨10.3390/cancers15020447⟩ Article dans une revue hal-03958279v1
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer Alice Mogenet,Pascal Finetti,Emilie Denicolai,Laurent Greillier,Pascaline Boudou-Rouquetteet al. Journal of Translational Medicine, 2023, 21 (1), pp.637. ⟨10.1186/s12967-023-04463-2⟩ Article dans une revue hal-04390901v1
Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer François Bertucci,Alexandre de Nonneville,Pascal Finetti,Emilie Mamessier Cancer Communications, 2023, 43 (8), pp.943-946. ⟨10.1002/cac2.12447⟩ Article dans une revue hal-04390884v1
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer Alice Mogenet,Pascal Finetti,Emilie Denicolai,Laurent Greillier,Pascaline Boudou-Rouquetteet al. Journal of Translational Medicine, 2023, 21 (1), pp.637. ⟨10.1186/s12967-023-04463-2⟩ Article dans une revue hal-04390234v1
The MonarchE trial: improving the clinical outcome in HR + /HER2 − early breast cancer: recent results and next steps François Bertucci,Pascal Finetti,Emilie Mamessier,Alexandre de Nonneville Cancer Communications, 2023, 43 (8), pp.938-942. ⟨10.1002/cac2.12466⟩ Article dans une revue hal-04390900v1
RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 François Bertucci,Alexandre de Nonneville,Pascal Finetti,Emilie Mamessier JNCI: Journal of the National Cancer Institute, 2023, 115 (6), pp.762-763. ⟨10.1093/jnci/djad060⟩ Article dans une revue hal-04390880v1
Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort Olivier Trédan,Maud Toulmonde,Christophe Le Tourneau,Laure Montane,Antoine Italianoet al. Cancers, 2023, 15, ⟨10.3390/cancers15133441⟩ Article dans une revue hal-04209734v1
First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter Bernadette de Rauglaudre,Pascal Finetti,David Jérémie Birnbaum,Marc Lopez,François Bertucciet al. Molecular Cancer Therapeutics, 2022, 21 (11), pp.1742-1743. ⟨10.1158/1535-7163.MCT-22-0240⟩ Article dans une revue hal-03958336v1
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature Francois Bertucci,Vincent Niziers,Alexandre de Nonneville,Pascal Finetti,Léna Mescamet al. Journal for Immunotherapy of Cancer, 2022, 10 (1), pp.e003687. ⟨10.1136/jitc-2021-003687⟩ Article dans une revue hal-03583256v1
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG) C. Moreau-Bachelard,L. Campion,M. Toulmonde,A. Le Cesne,M. Brahmiet al. ESMO Open, 2022, 7 (2), pp.100402. ⟨10.1016/j.esmoop.2022.100402⟩ Article dans une revue hal-03623511v1
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients Alexia Lopresti,Claire Acquaviva,Laurys Boudin,Pascal Finetti,Séverine Garnieret al. Cancers, 2022, 14 (4), pp.932. ⟨10.3390/cancers14040932⟩ Article dans une revue hal-03637735v1
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors Justine Gantzer,Guillaume Davidson,Bujamin Vokshi,Noëlle Weingertner,Antoine Bougoüinet al. Oncologist, 2022, ⟨10.1093/oncolo/oyac040⟩ Article dans une revue hal-03623495v1
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity Chaïma Cherif,Dang Tan Nguyen,Clément Paris,Thi Khanh Le,Thibaud Sefianeet al. Oncogene, 2022, 41 (1), pp.125-137. ⟨10.1038/s41388-021-02039-2⟩ Article dans une revue hal-03599176v1
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer Chang Gong,Ziliang Cheng,Yaping Yang,Jun Shen,Yingying Zhuet al. Science China Life Sciences, 2022, 65 (11), pp.2205-2217. ⟨10.1007/s11427-022-2104-3⟩ Article dans une revue hal-04085305v1
Pathological complete response rate and disease-free survival after neoadjuvant chemotherapy in patients with HER2-low and HER2-0 breast cancers Alexandre De Nonneville,Gilles Houvenaeghel,Monique Cohen,Laura Sabiani,Marie Bannieret al. European Journal of Cancer, 2022, 176, pp.181-188. ⟨10.1016/j.ejca.2022.09.017⟩ Article dans une revue hal-04084964v1
MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer Maroua Manai,Ines Elbini-Dhouib,Pascal Finetti,Haifa Bichiou,Carolina Reduzziet al. Cells, 2022, 11 (18), pp.2926. ⟨10.3390/cells11182926⟩ Article dans une revue hal-03958360v1
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients Alexia Lopresti,Claire Acquaviva,Laurys Boudin,Pascal Finetti,Séverine Garnieret al. Cancers, 2022, 14 (4), pp.932. ⟨10.3390/cancers14040932⟩ Article dans une revue hal-03583233v1
Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease Alban Macagno,Alexandre De Nonneville,Pierre Annede,Gilles Piana,Isabelle Pougnetet al. CURRENT ONCOLOGY, 2022, 29 (3), pp.1683-1694. ⟨10.3390/curroncol29030140⟩ Article dans une revue hal-04085333v1
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells Violette Azzoni,Julien Wicinski,Manon Macario,Martin Castagné,Pascal Finettiet al. Cell Death and Disease, 2022, 13 (2), pp.96. ⟨10.1038/s41419-022-04538-w⟩ Article dans une revue hal-05344102v1
Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression Victoire Gouirand,Tristan Gicquel,Evan Lien,Emilie Jaune‐pons,Quentin da Costaet al. EMBO Journal, 2022, ⟨10.15252/embj.2021110466⟩ Article dans une revue hal-03623502v1
RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis Alexandre de Nonneville,Pascal Finetti,Emilie Mamessier,François Bertucci JNCI: Journal of the National Cancer Institute, 2022, ⟨10.1093/jnci/djac031⟩ Article dans une revue hal-03583244v1
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC Charlotte Rypens,F. Bertucci,Pascal Finetti,Fredika Robertson,Sandra Fernandezet al. npj Breast Cancer, 2022, 8 (1), pp.12. ⟨10.1038/s41523-021-00379-6⟩ Article dans une revue hal-03623626v1
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells Violette Azzoni,Julien Wicinski,Manon Macario,Martin Castagné,Pascal Finettiet al. Cell Death and Disease, 2022, 13 (2), pp.96. ⟨10.1038/s41419-022-04538-w⟩ Article dans une revue hal-03623505v1
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT Alexandre de Nonneville,Sébastien Salas,François Bertucci,Alexander P Sobinoff,José Adélaïdeet al. EMBO Molecular Medicine, 2022, 14, ⟨10.15252/emmm.202215859⟩ Article dans une revue hal-03877721v1
Loss of primary cilia promotes inflammation and carcinogenesis Conception Paul,Ruizhi Tang,Ciro Longobardi,Rossano Lattanzio,Thibaut Eguetheret al. EMBO Reports, 2022, ⟨10.15252/embr.202255687⟩ Article dans une revue hal-03856745v1
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study Renaud Sabatier,Cécile Vicier,Séverine Garnier,Arnaud Guille,Nadine Carbucciaet al. Molecular Oncology, 2022, 16 (10), pp.2057-2070. ⟨10.1002/1878-0261.13188⟩ Article dans une revue hal-03583253v1
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy Mathias Neron,Arnaud Guille,Lucie Allègre,Pierre-Emmanuel Colombo,Cristina Marinella Leahaet al. Journal of Personalized Medicine, 2022, 12 (5), pp.655. ⟨10.3390/jpm12050655⟩ Article dans une revue hal-03765663v1
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression Laurys Boudin,Alexandre de Nonneville,Pascal Finetti,Geoffrey Guittard,Jacques Nuneset al. Cancers, 2022, 14 (14), pp.3356. ⟨10.3390/cancers14143356⟩ Article dans une revue hal-03765362v1
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response Alexandre De Nonneville,Pascal Finetti,Maelle Picard,Audrey Monneur,Maria Abbondanza Pantaleoet al. Cancers, 2022, 14 (5), ⟨10.3390/cancers14051306⟩ Article dans une revue hal-04085332v1
No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome? Yohan Fayet,Christine Chevreau,Gauthier Decanter,Cécile Dalban,Pierre Méeuset al. Cancers, 2022, 14 (11), pp.2620. ⟨10.3390/cancers14112620⟩ Article dans une revue hal-03718397v1
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial Émilien Billon,Gwenaelle Gravis,Arnaud Guille,Nadine Carbuccia,José Adélaïdeet al. Cancers, 2022, 14 (9), ⟨10.3390/cancers14092275⟩ Article dans une revue hal-04085310v1
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer Xiaoping Wang,Takashi Semba,Ganiraju C. Manyam,Jing Wang,Shan Shaoet al. Science Advances , 2022, 8 (50), ⟨10.1126/sciadv.abn7983⟩ Article dans une revue hal-04084958v1
CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response Laurys Boudin,A de Nonneville,Pascal Finetti,Léna Mescam,A Le Cesneet al. Journal of Translational Medicine, 2022, 20 (1), pp.464. ⟨10.1186/s12967-022-03679-y⟩ Article dans une revue hal-03958345v1
Évolution et facteurs associés à la publication des travaux de thèse d’exercice par les internes d’oncologie médicale en France Alexandre de Nonneville,F. Bertucci,Éric Lambaudie,Gilles Houvenaeghel,Renaud Sabatieret al. Bulletin du Cancer, 2022, ⟨10.1016/j.bulcan.2022.01.009⟩ Article dans une revue hal-03623519v1
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group Pascaline Boudou‐rouquette,Elodie Martin,Emmanuelle Kempf,Nicolas Penel,Maud Toulmondeet al. International Journal of Cancer, 2022, 150 (5), pp.825-836. ⟨10.1002/ijc.33837⟩ Article dans une revue hal-03560233v1
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer Yi Xiao,Ding Ma,Yun-Song Yang,Fan Yang,Jia-Han Dinget al. Cell Research, 2022, ⟨10.1038/s41422-022-00614-0⟩ Article dans une revue hal-03623509v1
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression Laurys Boudin,Alexandre de Nonneville,Pascal Finetti,Geoffrey Guittard,Jacques Nuneset al. Cancers, 2022, 14 (14), pp.3356. ⟨10.3390/cancers14143356⟩ Article dans une revue hal-04772648v1
Timing evolution of lobular breast cancer through phylogenetic analysis Danai Fimereli,David Venet,Mattia Rediti,Bram Boeckx,Marion Maetenset al. EBIOMEDICINE, 2022, 82, ⟨10.1016/j.ebiom.2022.104169⟩ Article dans une revue hal-04084988v1
Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA -mutant advanced breast cancer: Data from the French early access program. F. Bertucci,Diana Bello,Alexandre Bertucci,Thibault de La Motte Rouge,Cyriac Blonzet al. Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.1064-1064. ⟨10.1200/JCO.2021.39.15_suppl.1064⟩ Article dans une revue hal-03623116v1
EFA6B regulates a stop signal for collective invasion in breast cancer Racha Fayad,Monserrat Vázquez Rojas,Mariagrazia Partisani,Pascal Finetti,Shiraz Dibet al. Nature Communications, 2021, 12, pp.2198. ⟨10.1038/s41467-021-22522-4⟩ Article dans une revue hal-03434635v1
Case report: Two cases of metastatic pancreatoblastoma in adults: efficacy of Folfirinox and implication of the wnt/β-catenin pathway in genomic analysis Jean-Luc Raoul,Sandrine Oziel-Taieb,Thierry Lecomte,José Adelaide,Arnaud Guilleet al. Frontiers in Oncology, 2021, 11, pp.1-8. ⟨10.3389/fonc.2021.564506⟩ Article dans une revue hal-03623119v1
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial François Bertucci,Anthony Gonçalves,Arnaud Guille,José Adelaïde,Séverine Garnieret al. Genome Medicine, 2021, 13 (1), pp.87. ⟨10.1186/s13073-021-00897-9⟩ Article dans une revue hal-03583277v1
Determinants of the access to remote specialised services provided by national sarcoma reference centres Yohan Fayet,Raphaël Tétreau,Charles Honoré,Louis-Romée Le Nail,Cécile Dalbanet al. BMC Cancer, 2021, 21 (1), pp.631. ⟨10.1186/s12885-021-08393-4⟩ Article dans une revue inserm-03243378v1
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma David Birnbaum,Sebastian K.S. Begg,Pascal Finetti,Charles Vanderburg,Anupriya Kulkarniet al. Clinical Cancer Research, 2021, 27 (8), pp.2314-2325. ⟨10.1158/1078-0432.CCR-20-1039⟩ Article dans une revue hal-03623108v1
Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion Emilly Villodre,Xiaoding Hu,Richard Larson,Pascal Finetti,Kristen Gomezet al. Molecular Oncology, 2021, 15 (10), pp.2752-2765. ⟨10.1002/1878-0261.13074⟩ Article dans une revue hal-03623121v1
Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components Jean-Luc Raoul,Marie-Françoise Heymann,Frédéric Dumont,Alain Morel,Hélène Senellartet al. Frontiers in Oncology, 2021, 11, ⟨10.3389/fonc.2021.646992⟩ Article dans une revue hal-03623095v1
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME) D. Dano,A. Lardy-Cleaud,A. Monneur,N. Quenel-Tueux,C. Levyet al. ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩ Article dans une revue hal-03426433v1
Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy Gayathri Devi,Pascal Finetti,Michael Morse,Seayoung Lee,Alexandre de Nonnevilleet al. Cancers, 2021, 13 (11), pp.2807. ⟨10.3390/cancers13112807⟩ Article dans une revue hal-03623076v1
739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial Renaud Sabatier,Cécile Vicier,Séverine Garnier,Arnaud Guille,Nadine Carbucciaet al. Annals of Oncology, 2021, 32 (15_suppl), pp.S737-S738. ⟨10.1016/j.annonc.2021.08.1181⟩ Article dans une revue hal-03622737v1
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer Anthony Goncalves,Pascal Finetti,Daniel Birnbaum,F. Bertucci npj Breast Cancer, 2021, 7 (1), pp.48. ⟨10.1038/s41523-021-00256-2⟩ Article dans une revue hal-03623055v1
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery P. Pautier,A. Floquet,C. Chevreau,N. Penel,C. Guillemetet al. ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩ Article dans une revue hal-03623631v1
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion Stéphane Fattori,Laurent Gorvel,Samuel Granjeaud,Philippe Rochigneux,Marie-Sarah Rouvièreet al. Cancers, 2021, 13 (3), pp.441. ⟨10.3390/cancers13030441⟩ Article dans une revue hal-03152759v1
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment Dang Tan Nguyen,Thi Khanh Le,Clément Paris,Chaïma Cherif,Stéphane Audebertet al. Biomedicines, 2021, 9 (7), pp.795. ⟨10.3390/biomedicines9070795⟩ Article dans une revue hal-03599175v1
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets Yue Gong,Peng Ji,Yun-Song Yang,Shao Xie,Tian-Jian Yuet al. Cell Metabolism, 2021, 33 (1), pp.51-64.e9. ⟨10.1016/j.cmet.2020.10.012⟩ Article dans une revue hal-03623115v1
WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer Alexandre Nonneville,Pascal Finetti,Daniel Birnbaum,Emilie Mamessier,François Bertucci Advanced Science, 2021, 8 (17), pp.2101030. ⟨10.1002/advs.202101030⟩ Article dans une revue hal-03583269v1
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study Almudena Callejo,Sara Faouzi,Olivier Bouché,F. Bertucci,Thomas Chevalieret al. Targeted Oncology, 2021, 16 (4), pp.485-492. ⟨10.1007/s11523-021-00820-7⟩ Article dans une revue hal-03623633v1
A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans Julie Delyon,Raphael Porcher,Maxime Battistella,Nicolas Meyer,Henri Adamskiet al. Journal of Investigative Dermatology, 2021, 141 (4), pp.761-769.e2. ⟨10.1016/j.jid.2020.06.039⟩ Article dans une revue hal-03623658v1
The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Christophe van Berckelaer,Iris Vermeiren,Leonie Vercauteren,Charlotte Rypens,Gizem Oneret al. Cancers, 2021, 13 (18), pp.4656. ⟨10.3390/cancers13184656⟩ Article dans une revue hal-03623094v1
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors François Bertucci,Laurys Boudin,Pascal Finetti,Christophe van Berckelaer,Peter van Damet al. OncoImmunology, 2021, 10 (1), ⟨10.1080/2162402X.2021.1929724⟩ Article dans une revue hal-03583271v1
CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM Guillaume Belthier,Zeinab Homayed,Fanny Grillet,Christophe Duperray,Julie Vendrellet al. Cancers, 2021, 13 (19), pp.4966. ⟨10.3390/cancers13194966⟩ Article dans une revue hal-03394453v1
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial Ke-Da Yu,Xi-Yu Liu,Li Chen,Miao Mo,Jiong Wuet al. The Lancet Regional Health - Western Pacific, 2021, 11, pp.100158. ⟨10.1016/j.lanwpc.2021.100158⟩ Article dans une revue hal-03623636v1
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma. Angélina Acier,Magali Godard,Fanny Gassiot,Pascal Finetti,Marion Rubiset al. Communications Biology, 2021, 4 (1), pp.987. ⟨10.1038/s42003-021-02508-0⟩ Article dans une revue hal-03452855v1
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study Florence Duffaud,Antoine Italiano,Emannuelle Bompas,Maria Rios,Nicolas Penelet al. European Journal of Cancer, 2021, 150, pp.108-118. ⟨10.1016/j.ejca.2021.03.039⟩ Article dans une revue hal-03623638v1
Circulating tumor DNA as a noninvasive marker of resectability in ovarian carcinomas. Roxane Mari,Christophe Pomel,Pierre-Emmanuel Colombo,Fabrice Narducci,Séverine Garnieret al. Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.5548-5548. ⟨10.1200/JCO.2021.39.15_suppl.5548⟩ Article dans une revue hal-03622754v1
Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer Yuchen Guo,Monica Gabola,Rossano Lattanzio,Conception Paul,Valérie Pinetet al. Journal of Clinical Investigation, 2021, 131 (4), ⟨10.1172/JCI131517⟩ Article dans une revue hal-03152320v1
CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment Jean-Emmanuel Kurtz,Xavier Buy,Frédéric Deschamps,Erik Sauleau,Amine Bouhamamaet al. European Journal of Cancer, 2021, 143, pp.78-87. ⟨10.1016/j.ejca.2020.10.035⟩ Article dans une revue hal-03623642v1
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients Cecile Vicier,Patrick Sfumato,Nicolas Isambert,Florence Dalenc,Marie Robertet al. European Journal of Cancer, 2021, 159, pp.205-214. ⟨10.1016/j.ejca.2021.09.040⟩ Article dans une revue hal-03622797v1
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC Mabrouka Doghman-Bouguerra,Pascal Finetti,Nelly Durand,Ivy Zortéa S Parise,Silviu Sbieraet al. Cancers, 2020, 12, ⟨10.3390/cancers12030689⟩ Article dans une revue inserm-02508381v1
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib Nicolas Penel,Olivier Mir,Jennifer Wallet,Isabelle Ray-Coquard,Axel Le Cesneet al. European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩ Article dans une revue hal-03623680v1
Santé numérique et « cancer hors les murs », Big Data et intelligence artificielle Francois Bertucci,Anne-Gaëlle Le Corroller-Soriano,Audrey Monneur,Sylvain Fluzin,Patrice Vienset al. Bulletin du Cancer, 2020, 107 (1), pp.102-112. ⟨10.1016/j.bulcan.2019.07.006⟩ Article dans une revue hal-02505031v1
Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity Charlotte Rypens,Melike Marsan,Christophe van Berckelaer,Charlotte Billiet,Kirsten Meliset al. Breast Cancer Research and Treatment, 2020, 180 (2), pp.385-395. ⟨10.1007/s10549-020-05571-z⟩ Article dans une revue hal-03623677v1
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC Toshiaki Iwase,Kenichi Harano,Hiroko Masuda,Kumiko Kida,Kenneth R Hesset al. BMC Cancer, 2020, 20 (1), pp.430. ⟨10.1186/s12885-020-06940-z⟩ Article dans une revue inserm-02913696v1
PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond? Anthony Gonçalves,Alexandre Bertucci,François Bertucci Cancers, 2020, 12 (6), pp.1378. ⟨10.3390/cancers12061378⟩ Article dans une revue hal-03623672v1
Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting Bérengère Dadone-Montaudié,Audrey Laroche-Clary,Aline Mongis,Emmanuel Chamorey,Ilaria Di Mauroet al. Cancers, 2020, 12, ⟨10.3390/cancers12103058⟩ Article dans une revue hal-03034592v1
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer—Letter David Birnbaum,Pascal Finetti,Daniel Birnbaum,F. Bertucci Clinical Cancer Research, 2020, 26 (20), pp.5539-5539. ⟨10.1158/1078-0432.ccr-20-1969⟩ Article dans une revue hal-03623653v1
Neoplastic–Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer Kim Honselmann,Pascal Finetti,David Birnbaum,Christian Monsalve,Ulrich Wellneret al. Molecular Cancer Research, 2020, 18 (12), pp.1889-1902. ⟨10.1158/1541-7786.mcr-20-0439⟩ Article dans une revue hal-03623660v1
The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype François Bertucci,Pascal Finetti,Anthony Goncalves,Daniel Birnbaum npj Breast Cancer, 2020, 6 (1), pp.8. ⟨10.1038/s41523-020-0151-5⟩ Article dans une revue hal-03623676v1
Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins? Anaïs Aulas,Pascal Finetti,Shawn Lyons,François Bertucci,Daniel Birnbaumet al. Cancers, 2020, 12 (9), pp.2470. ⟨10.3390/cancers12092470⟩ Article dans une revue hal-03606494v1
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers François Bertucci,Charlotte Rypens,Pascal Finetti,Arnaud Guille,José Adélaïdeet al. Molecular Oncology, 2020, 14 (3), pp.504-519. ⟨10.1002/1878-0261.12621⟩ Article dans une revue hal-03623678v1
PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer Alexandre Bertucci,F. Bertucci,Christophe Zemmour,Florence Lerebours,Jean-Yves Piergaet al. Frontiers in Oncology, 2020, 10, ⟨10.3389/fonc.2020.575978⟩ Article dans une revue hal-03623650v1
Genomic landscape of inflammatory breast cancer identifies potential actionable genetic alterations François Bertucci,Steven Van Laere,Daniel Birnbaum Oncoscience, 2020, 7 (7-8), pp.57-59. ⟨10.18632/oncoscience.515⟩ Article dans une revue hal-03623667v1
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations A. Takedachi,E. Despras,S. Scaglione,R. Guérois,J. Guervillyet al. Nature Structural and Molecular Biology, 2020, 27 (5), pp.438-449. ⟨10.1038/s41594-020-0419-3⟩ Article dans une revue hal-03079782v1
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices? Essia Mezni,Cécile Vicier,Mathilde Guerin,Renaud Sabatier,François Bertucciet al. Cancers, 2020, 12 (6), pp.1573. ⟨10.3390/cancers12061573⟩ Article dans une revue hal-03623669v1
Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins? Anaïs Aulas,Pascal Finetti,Shawn M Lyons,François Bertucci,Daniel Birnbaumet al. Cancers, 2020, 12 (9), pp.2470. ⟨10.3390/cancers12092470⟩ Article dans une revue hal-02958029v1
ERBB2b mRNA isoform encodes a nuclear variant of the ERBB2 oncogene in breast cancer Guoqiang Hua,Aurélie Bergon,Pierre Cauchy,Brigitte Kahn‐perlès,François Bertucciet al. Journal of Cellular Biochemistry, 2020, ⟨10.1002/jcb.29762⟩ Article dans une revue hal-02897104v1
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study Mathias Neron,Christophe Sajous,Simon Thezenas,Sophie Piperno-Neumann,Fabien Reyalet al. Annals of Surgical Oncology, 2020, 27 (6), pp.1818-1827. ⟨10.1245/s10434-020-08217-y⟩ Article dans une revue hal-03623684v1
Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results Anthony Goncalves,Essia Mezni,F. Bertucci Current Opinion in Oncology, 2020, 32 (6), pp.585-593. ⟨10.1097/cco.0000000000000680⟩ Article dans une revue hal-03623648v1
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies Maud Toulmonde,Carlo Lucchesi,Stéphanie Verbeke,Amandine Crombe,Julien Adamet al. EBioMedicine, 2020, 62, ⟨10.1016/j.ebiom.2020.103131⟩ Article dans une revue hal-03034609v1
Publisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations A. Takedachi,E. Despras,S. Scaglione,R. Guérois,J. Guervillyet al. Nature Structural and Molecular Biology, 2020, 27 (6), pp.604-604. ⟨10.1038/s41594-020-0447-z⟩ Article dans une revue hal-02997075v1
Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions Evodie Peperstraete,Clément Lecerf,Jordan Collette,Constance Vennin,Ludivine Rabyet al. Cancers, 2020, 12 (7), pp.1730. ⟨10.3390/cancers12071730⟩ Article dans une revue hal-02896573v1
Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer François Richard,Samira Majjaj,David Venet,Françoise Rothé,Julien Pingitoreet al. Clinical Cancer Research, 2020, 26 (23), pp.6254-6265. ⟨10.1158/1078-0432.ccr-20-2268⟩ Article dans une revue hal-03623659v1
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma Maud Maillard,Christine Chevreau,Félicien Le Louedec,Manon Cassou,Caroline Delmaset al. Cancers, 2020, 12 (12), pp.3647. ⟨10.3390/cancers12123647⟩ Article dans une revue hal-03623645v1
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study) P. Pautier,N. Penel,I. Ray-Coquard,A. Italiano,E. Bompaset al. European Journal of Cancer, 2020, 125, pp.31-37. ⟨10.1016/j.ejca.2019.10.028⟩ Article dans une revue hal-02429038v1
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation Sylvain Garciaz,Lia N’guyen Dasi,Pascal Finetti,Christine Chevalier,Julien Vernereyet al. Clinical Epigenetics, 2019, 11 (1), ⟨10.1186/s13148-019-0738-6⟩ Article dans une revue hal-02322283v1
Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years Clémence Basse,Antoine Italiano,Nicolas Penel,Olivier Mir,Claire Cheminet al. International Journal of Cancer, 2019, 145 (8), pp.2135-2143. ⟨10.1002/ijc.32307⟩ Article dans une revue hal-02504786v1
Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls” François Bertucci,Anne-Gaëlle Le Corroller-Soriano,Audrey Monneur-Miramon,Jean-François Moulin,Sylvain Fluzinet al. Cancers, 2019, 11 (2), pp.219. ⟨10.3390/cancers11020219⟩ Article dans une revue inserm-02329449v1
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer Yi Xiao,Ding Ma,Shen Zhao,Chen Suo,Jinxiu Shiet al. Clinical Cancer Research, 2019, 25 (16), pp.5002-5014. ⟨10.1158/1078-0432.CCR-18-3524⟩ Article dans une revue hal-02533431v1
Surgery in reference centers improves survival of sarcoma patients: a nationwide study J.-Y. Blay,C. Honore,E. Stoeckle,P. Méeus,M. Jafariet al. Annals of Oncology, 2019, Annals of oncology official journal of the European Society for Medical Oncology, 30 (7), pp.1143-1153. ⟨10.1093/annonc/mdz124⟩ Article dans une revue hal-02509515v1
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response Jessica Roelands,Wouter Hendrickx,Gabriele Zoppoli,Raghvendra Mall,Mohamad Saadet al. Journal for Immunotherapy of Cancer, 2019, 8 (1), pp.e000617. ⟨10.1136/jitc-2020-000617⟩ Article dans une revue hal-03623675v1
ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer Luc Camoin,Jean-Paul Borg,Avais M Daulat,Pascal Finetti,Diego R Revinskiet al. British Journal of Cancer, 2019, 120 (9), pp.931-940. ⟨10.1038/s41416-019-0448-z⟩ Article dans une revue hal-02145896v1
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers Alexandre de Nonneville,Pascal Finetti,José Adelaïde,Eric Lambaudie,Patrice Vienset al. Cancers, 2019, 11 (8), pp.1158. ⟨10.3390/cancers11081158⟩ Article dans une revue hal-02518929v1
High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer Renaud Sabatier,Marc Lopez,Arnaud Guille,Emilien Billon,Nadine Carbucciaet al. JCO precision oncology, 2019, 3, pp.1-8. ⟨10.1200/po.18.00310⟩ Article dans une revue hal-03623686v1
XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma David Jérémie Birnbaum,Pascal Finetti,Daniel Birnbaum,Emilie Mamessier,Francois Bertucci Journal of Clinical Medicine, 2019, 8 (5), pp.596. ⟨10.3390/jcm8050596⟩ Article dans une revue hal-02509509v1
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study A. Le Cesne,P. Marec-Berard,J.-Y. Blay,N. Gaspar,F. Bertucciet al. European Journal of Cancer, 2019, 119, pp.151-157. ⟨10.1016/j.ejca.2019.07.018⟩ Article dans une revue hal-02529696v1
Author Correction: Genomic characterization of metastatic breast cancers Francois Bertucci,Charlotte Ng,Anne Patsouris,Nathalie Droin,Salvatore Piscuoglioet al. Nature, 2019, 572 (7767), pp.E7-E7. ⟨10.1038/s41586-019-1380-3⟩ Article dans une revue hal-02504834v1
Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution Luc Xerri,José Adelaïde,Morgan Avenin,Arnaud Guille,Sébastien Taixet al. Histopathology, 2019, 74 (4), pp.654-662. ⟨10.1111/his.13783⟩ Article dans une revue hal-02533424v1
PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma Emilien Billon,Pascal Finetti,Alexandre Bertucci,Patricia Niccoli,Daniel Birnbaumet al. OncoImmunology, 2019, 8 (11), pp.e1655362. ⟨10.1080/2162402X.2019.1655362⟩ Article dans une revue hal-02509464v1
Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression C. van Berckelaer,C. Rypens,P. van Dam,L. Pouillon,M. Parizelet al. Breast Cancer Research, 2019, 21 (1), pp.28. ⟨10.1186/s13058-019-1108-1⟩ Article dans une revue hal-02533387v1
Sensitive and easy screening for circulating tumor cells by flow cytometry Alexia Lopresti,Fabrice Malergue,François Bertucci,Maria Lucia Liberatoscioli,Séverine Garnieret al. JCI Insight, 2019, 4 (14), ⟨10.1172/jci.insight.128180⟩ Article dans une revue hal-02529764v1
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease Roxane Mari,Emilie Mamessier,Eric Lambaudie,Magali Provansal,Daniel Birnbaumet al. Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩ Article dans une revue hal-03606425v1
Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors David Birnbaum,François Bertucci,Pascal Finetti,Daniel Birnbaum,Emilie Mamessier Cancers, 2019, 11 (4), pp.497. ⟨10.3390/cancers11040497⟩ Article dans une revue hal-03583447v1
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study Mathias Neron,Christophe Sajous,Simon Thezenas,Sophie Piperno-Neumann,Fabien Reyalet al. Annals of Surgical Oncology, 2019, ⟨10.1245/s10434-019-08097-x⟩ Article dans une revue hal-02530556v1
PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target Francois Bertucci,Pascal Finetti,Audrey Monneur,Delphine Perrot,Christine Chevreauet al. Molecular Oncology, 2019, 13 (7), pp.1577-1588. ⟨10.1002/1878-0261.12522⟩ Article dans une revue hal-02504850v1
Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on “Cancer outside the Hospital Walls” Francois Bertucci,Anne-Gaëlle Le Corroller-Soriano,Audrey Monneur-Miramon,Jean-François Moulin,Sylvain Fluzinet al. Cancers, 2019, 11 (2), pp.219. ⟨10.3390/cancers11020219⟩ Article dans une revue hal-02504845v1
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group Marie Meurer,A. Floquet,I Ray-Coquard,F. Bertucci,M Auricheet al. International Journal of Gynecological Cancer, 2019, 29 (4), pp.691-698. ⟨10.1136/ijgc-2018-000064⟩ Article dans une revue hal-02530373v1
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells Abir Arfaoui,Claire Rioualen,Violette Azzoni,Guillaume Pinna,Pascal Finettiet al. EMBO Molecular Medicine, 2019, 11 (10), pp.e9930. ⟨10.15252/emmm.201809930⟩ Article dans une revue hal-02539524v1
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease Roxane Mari,Emilie Mamessier,Eric Lambaudie,Magali Provansal,Daniel Birnbaumet al. Cancers, 2019, 11 (6), pp.774. ⟨10.3390/cancers11060774⟩ Article dans une revue (article de synthèse) hal-02152656v1
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases Marguerite Tyran,Nadine Carbuccia,Séverine Garnier,Arnaud Guille,José Adelaïdeet al. Cancers, 2019, 11 (5), pp.665. ⟨10.3390/cancers11050665⟩ Article dans une revue hal-02533361v1
Genomic characterization of metastatic breast cancers Francois Bertucci,Charlotte Ng,Anne Patsouris,Nathalie Droin,Salvatore Piscuoglioet al. Nature, 2019, 569 (7757), pp.560-564. ⟨10.1038/s41586-019-1056-z⟩ Article dans une revue hal-02504838v1
Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade F. Bertucci,P. Finetti,A. Monneur,D. Birnbaum Annals of Oncology, 2019, 30 (2), pp.342-343. ⟨10.1093/annonc/mdy528⟩ Article dans une revue hal-02505000v1
ESR1 mutations in metastatic lobular breast cancer patients Christine Desmedt,Julien Pingitore,Françoise Rothé,Caterina Marchio,Florian Clatotet al. npj Breast Cancer, 2019, 5 (1), ⟨10.1038/s41523-019-0104-z⟩ Article dans une revue hal-02352890v1
Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour Alexandre Bertucci,Jérôme Guiramand,Lena Mescam,Audrey Monneur,Magali Bisbalet al. Case Reports in Oncology, 2019, 12 (2), pp.644-649. ⟨10.1159/000502338⟩ Article dans une revue hal-02504820v1
Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer Maroua Manai,Raoudha Doghri,Pascal Finetti,Karima Mrad,Rihab Bouabsaet al. In Vivo, 2019, 34 (1), pp.177-184. ⟨10.21873/invivo.11759⟩ Article dans une revue hal-03623682v1
Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study Maud Toulmonde,Marina Pulido,Isabelle Ray-Coquard,Thierry André,Nicolas Isambertet al. Lancet Oncology, 2019, 20 (9), pp.1263-1272. ⟨10.1016/S1470-2045(19)30276-1⟩ Article dans une revue hal-02533355v1
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients C. Honore,J.B. Delhorme,E. Nassif,M. Faron,G. Ferronet al. Surgical Oncology, 2019, 29, pp.107-112. ⟨10.1016/j.suronc.2019.04.002⟩ Article dans une revue istex hal-02528457v1
Results of API–AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study Sophie Piperno-Neumann,Isabelle Ray-Coquard,Bob-Valéry Occean,Valérie Laurence,Didier Cupissolet al. International Journal of Cancer, 2019, 146 (2), pp.413-423. ⟨10.1002/ijc.32526⟩ Article dans une revue hal-02530602v1
PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma Emilien Billon,Pascal Finetti,Alexandre Bertucci,Patricia Niccoli,Daniel Birnbaumet al. OncoImmunology, 2019, 8 (11), pp.e1655362. ⟨10.1080/2162402X.2019.1655362⟩ Article dans une revue hal-03606482v1
MARCKS protein overexpression is associated with poor prognosis in male breast cancer Maroua Manai,Syrine Abdeljaoued,Aïda Goucha,Olfa Adouni,Ilhem Bettaiebet al. Cancer Biomarkers, 2019, 26 (4), pp.513-522. ⟨10.3233/CBM-190637⟩ Article dans une revue hal-02530358v1
Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin Alexandre De Nonneville,Dominique Barbolosi,Maeva Andriantsoa,Raouf El-Cheikh,Florence Duffaudet al. Contemporary Southeast Asia, 2019, 11 (3), pp.432. ⟨10.3390/cancers11030432⟩ Article dans une revue hal-02461464v1
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review Gabrielle Planes-Laine,Philippe Rochigneux,François Bertucci,Anne-Sophie Chrétien,Patrice Vienset al. Cancers, 2019, 11 (7), pp.1033. ⟨10.3390/cancers11071033⟩ Article dans une revue (article de synthèse) hal-02533030v1
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer Renaud Sabatier,Emmanuelle Charafe-Jauffret,Jean-Yves Pierga,Hervé Curé,Eric Lambaudieet al. Journal of Clinical Medicine Research, 2019, 8 (5), pp.612. ⟨10.3390/jcm8050612⟩ Article dans une revue hal-02145624v1
Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B Lorène Seguin,Max Chaffanet,Séverine Garnier,José Adélaïde,Nadine Carbucciaet al. JCO precision oncology, 2019, 3, pp.1-9. ⟨10.1200/po.18.00362⟩ Article dans une revue hal-03623688v1
Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives? Emanuel Nicolas,Francois Bertucci,Renaud Sabatier,Anthony Goncalves Cancers, 2018, 10 (12), ⟨10.3390/cancers10120506⟩ Article dans une revue hal-02143625v1
``Wnt/beta-Catenin in GIST''-Letter Francois Bertucci,Pascal Finetti,Alexandre de Nonneville,Daniel Birnbaum MOLECULAR CANCER THERAPEUTICS, 2018, 17 (1), pp.327-328. ⟨10.1158/1535-7163.MCT-17-0948⟩ Article dans une revue hal-02143618v1
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer François Bertucci,Pascal Finetti,Ines Simeone,Wouter Hendrickx,Ena Wanget al. British Journal of Cancer, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩ Article dans une revue hal-03606514v1
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial Loïc Lebellec,François Bertucci,Emmanuelle Tresch-Bruneel,Isabelle Ray-Coquard,Axel Le Cesneet al. BMC Cancer, 2018, 18 (1), pp.963. ⟨10.1186/s12885-018-4828-1⟩ Article dans une revue inserm-02050851v1
CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors Emilie Mamessier,David Birnbaum,Pascal Finetti,Daniel Birnbaum,François Bertucci Annals of translational medicine, 2018, 6 (3), pp.54 - 54. ⟨10.21037/atm.2017.11.26⟩ Article dans une revue hal-01765411v1
PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer Audrey Monneur,Anthony Goncalves,Francois Bertucci Bulletin du Cancer, 2018, 105 (3), pp.261-272. ⟨10.1016/j.bulcan.2017.11.012⟩ Article dans une revue hal-02143676v1
Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo‑clinical features and therapeutic results Maroua Manai,Pascal Finetti,Nesrine Mejri,Salma Athimni,Daniel Birnbaumet al. Molecular and Clinical Oncology, 2018, 10 (2), pp.223-230. ⟨10.3892/mco.2018.1773⟩ Article dans une revue hal-02530356v1
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer Francois Bertucci,Pascal Finetti,Ines Simeone,Wouter Hendrickx,Ena Wanget al. Breast Cancer Research and Treatment, 2018, 119 (11), pp.1383-1391. ⟨10.1038/s41416-018-0309-1⟩ Article dans une revue hal-02143596v1
The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/beta-Catenin Signaling Leonor Lopez Almeida,Michael Sebbagh,Francois Bertucci,Pascal Finetti,Julien Wicinskiet al. Stem Cell Reports, 2018, 11 (5), pp.1040-1050. ⟨10.1016/j.stemcr.2018.09.008⟩ Article dans une revue hal-02143631v1
Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma Nuria Kotecki,Axel Le Cesne,Emmanuelle Tresch-Bruneel,Isabelle Ray-Coquard,Christine Chevreauet al. American Journal of Clinical Oncology, 2018, 41 (11), pp.1094-1100. ⟨10.1097/coc.0000000000000430⟩ Article dans une revue hal-03623697v1
Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review Marie Cantaloube,Laurence Moureau-Zabotto,Lena Mescam,Audrey Monneur,Valeria Delucaet al. Case Reports in Oncology, 2018, 11 (1), pp.21-28. ⟨10.1159/000485740⟩ Article dans une revue hal-02143619v1
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma F Bertucci,A de Nonneville,P Finetti,D Perrot,M Nilbertet al. Annals of Oncology, 2018, 29 (2), pp.459 - 465. ⟨10.1093/annonc/mdx699⟩ Article dans une revue hal-01787485v1
Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma Christine Desmedt,Roberto Salgado,Marco Fornili,Giancarlo Pruneri,Gert van den Eyndenet al. European Journal of Cancer, 2018, 99 (7), pp.28-36. ⟨10.1016/j.ejca.2018.05.008⟩ Article dans une revue istex hal-03623702v1
Giant Pedunculated Hepatic Hemangioma: A Case Report and Literature Review Abdallah Al farai,Lénaïg Mescam,Valeria De luca,Audrey Monneur,Delphine Perrotet al. Case Reports in Oncology, 2018, 11 (2), pp.476-484. ⟨10.1159/000490696⟩ Article dans une revue hal-03623704v1
Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy Raoudha Boughzala-Bennadji,Eberhard Stoeckle,Cécile Le Péchoux,Pierre Méeus,Charles Honoréet al. International Journal of Radiation Oncology, Biology, Physics, 2018, 102 (2), pp.399-406. ⟨10.1016/j.ijrobp.2018.05.055⟩ Article dans une revue hal-02049039v1
CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors Luc Xerri,José Adelaïde,Cornel Popovici,Séverine Garnier,Arnaud Guilleet al. American Journal of Surgical Pathology, 2018, 42 (2), pp.150 - 159. ⟨10.1097/PAS.0000000000000989⟩ Article dans une revue hal-01788565v1
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype Kenichi Harano,Ying Wang,Bora Lim,Robert S. Seitz,Stephan W. Morriset al. PLoS ONE, 2018, 13 (10), pp.e0204513. ⟨10.1371/journal.pone.0204513⟩ Article dans une revue hal-02143557v1
Poly (ADP-Ribose) Polymerase Inhibitors for De Novo BRCA2-Null Small-Cell Prostate Cancer Brice Chanez,Max Chaffanet,José Adélaide,Jeanne Thomassin,Séverine Garnieret al. JCO precision oncology, 2018, 2, pp.1-8. ⟨10.1200/po.18.00083⟩ Article dans une revue hal-03623699v1
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer David Birnbaum,François Bertucci,Pascal Finetti,Daniel Birnbaum,Emilie Mamessier Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018, 1869 (2), pp.248-255. ⟨10.1016/j.bbcan.2018.02.001⟩ Article dans une revue hal-03583468v1
Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives? Emanuel Nicolas,François Bertucci,Renaud Sabatier,Anthony Gonçalves Cancers, 2018, 10 (12), pp.506. ⟨10.3390/cancers10120506⟩ Article dans une revue hal-03669695v1
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer Renaud Sabatier,Véronique Diéras,Xavier B. Pivot,Etienne Brain,Henri Rocheet al. Breast Cancer Research and Treatment, 2018, 50 (4), pp.1226-1237. ⟨10.4143/crt.2017.446⟩ Article dans une revue inserm-01985845v1
Reversible rituximab-induced rectal Kaposi's sarcoma misdiagnosed as ulcerative colitis in a patient with HIV-negative follicular lymphoma Emilien Billon,Anne-Marie Stoppa,Lena Mescam,Massimo Bocci,Audrey Monneuret al. CLINICAL SARCOMA RESEARCH, 2018, 8, ⟨10.1186/s13569-018-0097-7⟩ Article dans une revue hal-02143666v1
Ex vivo CSC assays for personalized testing of drug susceptibility in advanced breast cancer Emmanuelle Charafe-Jauffret,Julien Wicinski,Olivier Cabaud,Marc Lopez,Stephane Audebertet al. Cancer Research, 2018, 78 (4, S) Article dans une revue hal-02143678v1
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib Olivier Bouché,Axel Le Cesne,Maria Rios,Loic Chaigneau,Antoine Italianoet al. PLoS ONE, 2018, 13 (9), pp.e0204117. ⟨10.1371/journal.pone.0204117⟩ Article dans une revue hal-02005925v1
Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value Raoudha Doghri,Maroua Manai,Pascal Finetti,Maha Driss,Emilie Agavnianet al. International Journal of Molecular Sciences, 2018, 19 (1), ⟨10.3390/ijms19010041⟩ Article dans une revue hal-02143620v1
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer Mathilde Guérin,Anthony Gonçalves,Yves Toiron,Emilie Baudelet,Matthieu Pophillatet al. Oncotarget, 2018, 9 (73), pp.33762-33777. ⟨10.18632/oncotarget.26031⟩ Article dans une revue hal-02145636v1
A major response to carboplatin in a metastatic triple-negative breast cancer patient with somatic mutation of BRCA1 and RAD51B: When chemotherapy meets precision medicine L. Seguin,M. Chaffanet,R. Sabatier,A. Jose,S. Garnieret al. Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy314.030⟩ Article dans une revue hal-02143656v1
Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care Alexandre de Nonneville,François Bertucci,Pascal Finetti,D. Perrot,M. Nilbertet al. BMC Palliative Care, 2018, 17 (1), pp.104. ⟨10.1186/s12904-018-0357-6⟩ Article dans une revue hal-03583406v1
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database S. Salas,N. Resseguier,Jean-Yves Blay,A. Le Cesne,A. Italianoet al. Annals of Oncology, 2017, 28 (8), pp.1979 - 1987. ⟨10.1093/annonc/mdx250⟩ Article dans une revue hal-01655970v1
Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas—Letter François Bertucci,Pascal Finetti,Daniel Birnbaum Molecular Cancer Therapeutics, 2017, 16 (10), pp.2324 - 2324. ⟨10.1158/1535-7163.MCT-17-0491⟩ Article dans une revue hal-01787271v1
A 25-gene classifier predicts overall survival in resectable pancreatic cancer David Birnbaum,Pascal Finetti,Alexia Lopresti,Marine Gilabert,Flora Poizatet al. BMC Medicine, 2017, 15 (1), ⟨10.1186/s12916-017-0936-z⟩ Article dans une revue hal-01787872v1
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling Rita El Helou,Guillaume Pinna,Olivier Cabaud,Julien Wicinski,Ricky Bhajunet al. Cell Reports, 2017, 18 (9), pp.2256-2268. ⟨10.1016/j.celrep.2017.02.016⟩ Article dans une revue hal-01789620v1
Prognostic Value of Molecular Subtypes in Pancreatic Cancer François Bertucci,David Birnbaum,Pascal Finetti,Marine Gilabert,Flora Poizatet al. Pancreas, 2017, 46 (4), pp.e29-e31. ⟨10.1097/MPA.0000000000000787⟩ Article dans une revue hal-03606452v1
Gastrointestinal Stromal Tumour with Synchronous Bone Metastases: A Case Report and Literature Review Philippe Rochigneux,Lénaig Mescam-Mancini,Delphine Perrot,Erwan Bories,Laurence Moureau-Zabottoet al. Case Reports in Oncology, 2017, 10 (1), pp.66-76. ⟨10.1159/000455188⟩ Article dans une revue hal-03623722v1
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas François Bertucci,Pascal Finetti,Delphine Perrot,Agnès Leroux,Françoise Collinet al. OncoImmunology, 2017, 6 (3), pp.e1278100. ⟨10.1080/2162402X.2016.1278100⟩ Article dans une revue hal-01765418v1
Nectine-4 : un biomarqueur pronostique et une cible thérapeutique potentielle dans le cancer du sein triple-négatif Manel M 'Rabet,François Bertucci,Daniel Birnbaum,Marc Lopez Médecine/Sciences, 2017 Article dans une revue hal-01788721v1
Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1 François Bertucci,Anthony Gonçalves Current Oncology Reports, 2017, 19 (10), pp.64. ⟨10.1007/s11912-017-0627-0⟩ Article dans une revue hal-03623712v1
A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome Pauline Rochefort,Antoine Italiano,Valérie Laurence,Nicolas Penel,Audrey Lardy-Cleaudet al. Scientific Reports, 2017, Scientific reports, 7, ⟨10.1038/s41598-017-17733-z⟩ Article dans une revue hal-02613645v1
Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis Vincent Berry,Laurent Basson,Emilie Bogart,Olivier Mir,Jean-Yves Blayet al. Cancer, 2017, Cancer, 123, pp.2294-2302. ⟨10.1002/cncr.30661⟩ Article dans une revue hal-02638646v1
Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC) Madhura Joglekar-Javadekar,Steven van Laere,Michael Bourne,Manal Moalwi,Pascal Finettiet al. Neoplasia, 2017, 19 (7), pp.564-573. ⟨10.1016/j.neo.2017.03.002⟩ Article dans une revue hal-01789694v1
A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study Brice Chanez,François Bertucci,Marine Gilabert,Anne Madroszyk,Frédérique Rousseauet al. Supportive Care in Cancer, 2017, 25 (9), pp.2715-2722. ⟨10.1007/s00520-017-3680-1⟩ Article dans une revue hal-03623718v1
MARCKS protein overexpression in inflammatory breast cancer Maroua Manai,Jeanne Thomassin-Piana,Amor Gamoudi,Pascal Finetti,Marc Lopezet al. Oncotarget, 2017, 8, pp.6246 - 6257. ⟨10.18632/oncotarget.14057⟩ Article dans une revue hal-01787705v1
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]. Laurys Boudin,Christian Chabannon,Patrick Sfumato,Renaud Sabatier,François Bertucciet al. Bulletin du Cancer, 2017, 104 (4), pp.332 - 343. ⟨10.1016/j.bulcan.2016.12.007⟩ Article dans une revue hal-01788977v1
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis Wouter Hendrickx,Ines Simeone,Samreen Anjum,Younes Mokrab,François Bertucciet al. OncoImmunology, 2017, 6 (2), ⟨10.1080/2162402X.2016.1253654⟩ Article dans une revue hal-01788951v1
An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signatures François Bertucci,Max Chaffanet,Daniel Birnbaum Chinese Clinical Oncology, 2017, 6 (1), pp.4 - 4. ⟨10.21037/cco.2016.11.01⟩ Article dans une revue hal-01787356v1
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers Preeti Putcha,Jiyang Yu,Ruth Rodriguez-Barrueco,Laura Saucedo-Cuevas,Patricia Villagrasaet al. Breast Cancer Research, 2017, 19 (1), pp.49. ⟨10.1186/s13058-017-0841-6⟩ Article dans une revue hal-03623716v1
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group Nicolas Penel,Axel Le Cesne,Sylvie Bonvalot,Antoine Giraud,Emmanuelle Bompaset al. European Journal of Cancer, 2017, 83, pp.125-131. ⟨10.1016/j.ejca.2017.06.017⟩ Article dans une revue istex hal-03623713v1
Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study A. de Nonneville,A. Goncalves,C. Zemmour,M. Cohen,J.M. Classeet al. European Journal of Cancer, 2017, 84, pp.34-43. ⟨10.1016/j.ejca.2017.06.043⟩ Article dans une revue hal-02282824v1
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer M. M-Rabet,O. Cabaud,E. Josselin,P. Finetti,R. Castellanoet al. Annals of Oncology, 2017, ⟨10.1093/annonc/mdw678⟩ Article dans une revue hal-01787533v1
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy Ruth Rodriguez-Barrueco,Erin A Nekritz,François Bertucci,Jiyang Yu,Felix Sanchez-Garciaet al. Genes and Development, 2017, 31 (6), pp.553-566. ⟨10.1101/gad.292318.116⟩ Article dans une revue hal-01787959v1
A stemness-related ZEB1–MSRB3 axis governs cellular pliancy and breast cancer genome stability Anne Morel,Christophe Ginestier,Roxane Pommier,Olivier Cabaud,Emmanuelle Ruizet al. Nature Medicine, 2017, 23 (5), pp.568 - 578. ⟨10.1038/nm.4323⟩ Article dans une revue hal-01788395v1
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers Audrey Monneur,Anthony Gonçalves,Marine Gilabert,Pascal Finetti,Carole Tarpinet al. Oncotarget, 2017, 8 (39), pp.66019 - 66032. ⟨10.18632/oncotarget.19732⟩ Article dans une revue inserm-01984755v1
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study Alexandre de Nonneville,Anthony Gonçalves,Christophe Zemmour,Jean Classe,Monique Cohenet al. Breast Cancer Research and Treatment, 2017, 162 (2), pp.307-316. ⟨10.1007/s10549-017-4136-5⟩ Article dans une revue hal-03623719v1
Scientific summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) program 10th Anniversary Conference Wendy Woodward,Massimo Cristofanilli,Sofia Merajver,Steven van Laere,Lajos Pusztaiet al. Journal of Cancer, 2017, 8 (17), pp.3607-3614. ⟨10.7150/jca.21200⟩ Article dans une revue hal-03623708v1
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF) Loïc Lebellec,Bruno Chauffert,Jean-Yves Blay,Axel Le Cesne,Christine Chevreauet al. European Journal of Cancer, 2017, 79, pp.119 - 128. ⟨10.1016/j.ejca.2017.03.037⟩ Article dans une revue istex hal-01655981v1
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer Mathilde Guerin,Keyvan Rezai,Nicolas Isambert,Mario Campone,Aurélie Autretet al. European Journal of Cancer, 2017, 86, pp.28-36. ⟨10.1016/j.ejca.2017.08.025⟩ Article dans une revue istex hal-03623711v1
The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations? Anthony Gonçalves,Audrey Monneur,Patrice Viens,François Bertucci Expert Review of Anticancer Therapy, 2017, 17 (7), pp.593-606. ⟨10.1080/14737140.2017.1330655⟩ Article dans une revue hal-03623715v1
Validation and comparison of the molecular classifications of pancreatic carcinomas David Birnbaum,Pascal Finetti,Daniel Birnbaum,Emilie Mamessier,François Bertucci Molecular Cancer, 2017, 16 (1), pp.168. ⟨10.1186/s12943-017-0739-z⟩ Article dans une revue hal-03583469v1
Circulating Tumour Cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab Jean-Yves Pierga,François-Clément Bidard,A. Autret,Tillys Petit,Frédéric Andréet al. Annals of Oncology, 2017, 28, pp.mdw535. ⟨10.1093/annonc/mdw535⟩ Article dans une revue inserm-01985299v1
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study Laurys Boudin,Anthony Gonçalves,Patrick Sfumato,Renaud Sabatier,François Bertucciet al. American Journal of Cancer, 2016, 7 (14), pp.2077-2084. ⟨10.7150/jca.15797⟩ Article dans une revue inserm-01987531v1
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer Tania M. Puvirajesinghe,François Bertucci,Ashish Jain,Pierluigi Scerbo,Edwige Belottiet al. Nature Communications, 2016, 7, pp.10318. ⟨10.1038/ncomms10318⟩ Article dans une revue hal-01447570v1
PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progression Christelle Vincent-Fabert,Nadine Platet,Amelle Vandevelde,Mathilde Poplineau,Myriam Koubiet al. Blood, 2016, 127 (15), pp.1881-1885. ⟨10.1182/blood-2015-09-666974⟩ Article dans une revue hal-03623736v1
Comparative genomic analysis of primary tumors and metastases in breast cancer François Bertucci,Pascal Finetti,Arnaud Guille,José Adélaïde,Séverine Garnieret al. Oncotarget, 2016, 7 (19), pp.27208-27219. ⟨10.18632/oncotarget.8349⟩ Article dans une revue hal-03623731v1
Prognostic value of &lt;i&gt;PDL1&lt;/i&gt; expression in pancreatic cancer David Birnbaum,Pascal Finetti,Alexia Lopresti,Marine Gilabert,Flora Poizatet al. Oncotarget, 2016, 7 (44), ⟨10.18632/oncotarget.11685⟩ Article dans une revue hal-01765421v1
Pregnane X-receptor promotes stem cell-mediated colon cancer relapse Chris Planque,Fatemeh Rajabi,Fanny Grillet,Pascal Finetti,François Bertucciet al. Oncotarget, 2016, 7 (35), pp.56558-56573. ⟨10.18632/oncotarget.10646⟩ Article dans une revue hal-01431926v1
SPAG5: the ultimate marker of proliferation in early breast cancer? François Bertucci,Patrice Viens,Daniel Birnbaum Lancet Oncology, 2016, 17 (7), pp.863-865. ⟨10.1016/s1470-2045(16)30092-4⟩ Article dans une revue hal-03623730v1
Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group A. Patrikidou,J. Domont,Sylvie Chabaud,Isabelle Ray-Coquard,J.M. Coindreet al. European Journal of Cancer, 2016, 52, pp.173--180. ⟨10.1016/j.ejca.2015.10.069⟩ Article dans une revue istex hal-01812685v1
XPO1, therapeutic...and prognostic target in sarcomas François Bertucci,Pascal Finetti,Daniel Birnbaum Oncoscience, 2016, 3 (5-6), pp.143-144. ⟨10.18632/oncoscience.304⟩ Article dans une revue hal-03623732v1
Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts). Loic Lebellec,Axel Le Cesne,Nicolas Penel,Jean -Yves Blay,Christine Chevreauet al. Journal of Clinical Oncology, 2016, 34 (15, S), ⟨10.1200/JCO.2016.34.15\_suppl.11020⟩ Article dans une revue hal-03598684v1
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study Anthony Gonçalves,François Bertucci,Arnaud Guille,Severine Garnier,José Adelaideet al. Oncotarget, 2016, 7 (48), pp.79428-79441. ⟨10.18632/oncotarget.12714⟩ Article dans une revue hal-03623724v1
Genomic Characterization of Primary Invasive Lobular Breast Cancer Christine Desmedt,Gabriele Zoppoli,Gunes Gundem,Giancarlo Pruneri,Denis Larsimontet al. Journal of Clinical Oncology, 2016, 34 (16), pp.1872-1881. ⟨10.1200/jco.2015.64.0334⟩ Article dans une revue hal-03623737v1
MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study Emeline Tabouret,François Bertucci,Jean-Yves Pierga,Thierry Petit,Christelle Levyet al. Oncotarget, 2016, 7 (14), pp.18531-18540. ⟨10.18632/oncotarget.7612⟩ Article dans une revue hal-03623733v1
Autocrine Secretion of Progastrin Promotes the Survival and Self-Renewal of Colon Cancer Stem-like Cells Julie Giraud,Laura Failla,Jean-Marc Pascussi,Ebba Louise Lagerqvist,Jérémy Ollieret al. Cancer Research, 2016, 76 (12), pp.3618 - 3628. ⟨10.1158/0008-5472.CAN-15-1497⟩ Article dans une revue hal-01905320v1
Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France N. Penel,J.M. Coindre,S. Bonvalot,A. Italiano,A. Neuvilleet al. European Journal of Cancer, 2016, 58, pp.90--96. ⟨10.1016/j.ejca.2016.02.008⟩ Article dans une revue hal-01812682v1
Bevacizumab in HER2-negative inflammatory breast cancer François Bertucci,Anthony Goncalves,Patrice Viens Oncoscience, 2016, 3 (11-12), pp.297-298. ⟨10.18632/oncoscience.324⟩ Article dans une revue hal-03623723v1
Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma. David Birnbaum,François Bertucci,Pascal Finetti,José Adélaïde,Marc Giovanniniet al. Cancer Genomics and Proteomics, 2016, 13 (3), pp.191-200 Article dans une revue hal-03583479v1
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial Olivier Mir,Claire Cropet,Maud Toulmonde,Axel Le Cesne,Mathieu Molimardet al. Lancet Oncology, 2016, 17 (5), pp.632-641. ⟨10.1016/s1470-2045(16)00075-9⟩ Article dans une revue hal-03623734v1
Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO) Loic Lebellec,François Bertucci,Emmanuelle Tresch-Bruneel,Emmanuelle Bompas,Yves Toironet al. Oncotarget, 2016, Oncotarget, 7 (45), pp.73984-73994. ⟨10.18632/oncotarget.12172⟩ Article dans une revue hal-01453300v1
PRICKLE1 contributes to cancer cell dissemination through its interaction with mTORC2 Avais M Daulat,François Bertucci,Stéphane Audebert,Arnauld Sergé,Pascal Finettiet al. Developmental Cell, 2016, 37, pp.311-325. ⟨10.1016/j.devcel.2016.04.011⟩ Article dans une revue hal-01321061v1
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial Olivier Mir,Thomas Brodowicz,Antoine Italiano,Jennifer Wallet,Jean-Yves Blayet al. Lancet Oncology, 2016, 17 (12), pp.1732-1742. ⟨10.1016/s1470-2045(16)30507-1⟩ Article dans une revue istex hal-03623726v1
Prognostic value of PDL1 expression in pancreatic cancer David Birnbaum,Pascal Finetti,Alexia Lopresti,Marine Gilabert,Flora Poizatet al. Oncotarget, 2016, 7 (44), pp.71198-71210. ⟨10.18632/oncotarget.11685⟩ Article dans une revue hal-03583475v1
Corrigendum to “Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation” [Eur J Cancer 57 (April 2016) 118–126] Laurys Boudin,Christian Chabannon,Patrick Sfumato,Renaud Sabatier,François Bertucciet al. European Journal of Cancer, 2016, 67, pp.223. ⟨10.1016/j.ejca.2016.09.002⟩ Article dans une revue istex hal-03623727v1
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study François Bertucci,Mahmoud Fekih,Aurélie Autret,Thierry Petit,Florence Dalencet al. Lancet Oncology, 2016, 17 (5), pp.600-611. ⟨10.1016/s1470-2045(16)00011-5⟩ Article dans une revue istex hal-03623735v1
Systems biology analysis of gene expression data and gene network reverse-engineering approaches reveal NFAT5 as a candidate biomarker in Inflammatory Breast Cancer Andrea Remo,Ines Simeone,Massimo Pancione,Pietro Parcesepe,Pascal Finettiet al. Journal for Immunotherapy of Cancer, 2015, 3 (Suppl 1), pp.P6. ⟨10.1186/2051-1426-3-s1-p6⟩ Article dans une revue hal-03623751v1
High-grade soft tissue sarcoma arising in a desmoid tumor: case report and review of the literature François Bertucci,Marjorie Faure,Maria-Rosa Ghigna,Bruno Chetaille,Jérôme Guiramandet al. Clinical Sarcoma Research, 2015, 5 (1), pp.25. ⟨10.1186/s13569-015-0040-0⟩ Article dans une revue hal-03623738v1
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease Maurice P.H.M. Jansen,Leen Sas,Anieta Sieuwerts,Caroline van Cauwenberghe,Diana Ramirez-Ardilaet al. Molecular Oncology, 2015, 9 (6), pp.1218-1233. ⟨10.1016/j.molonc.2015.02.006⟩ Article dans une revue hal-03623744v1
Prediction of Early Breast Cancer Metastasis from DNA Microarray Data Using High-Dimensional Cox Regression Models Christophe Zemmour,Francois Bertucci,Pascal Finetti,Bernard Chetrit,Daniel Birnbaumet al. Cancer Informatics, 2015, 14(Suppl 2), pp.129-138. ⟨10.4137/cin.s17284⟩ Article dans une revue inserm-01996812v1
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers François Bertucci,Pascal Finetti,Daniel Birnbaum,Emilie Mamessier OncoImmunology, 2015, 5 (3), pp.e1085148. ⟨10.1080/2162402X.2015.1085148⟩ Article dans une revue hal-03583477v1
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers Preeti Putcha,Jiyang Yu,Ruth Rodriguez-Barrueco,Laura Saucedo-Cuevas,Patricia Villagrasaet al. Breast Cancer Research, 2015, 17 (1), pp.149. ⟨10.1186/s13058-015-0658-0⟩ Article dans une revue inserm-01254136v1
&lt;i&gt;H19&lt;/i&gt; non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b Constance Vennin,Nathalie Spruyt,Fatima Dahmani,Sylvain Julien,François Bertucciet al. Oncotarget, 2015, 6 (30), ⟨10.18632/oncotarget.4976⟩ Article dans une revue hal-02347866v1
Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group Axel Le Cesne,Isabelle Ray-Coquard,Florence Duffaud,Christine Chevreau,Nicolas Penelet al. European Journal of Cancer, 2015, 51 (6), pp.742-750. ⟨10.1016/j.ejca.2015.01.006⟩ Article dans une revue istex hal-03623749v1
PDL1 expression is an independent prognostic factor in localized GIST François Bertucci,Pascal Finetti,Emilie Mamessier,Maria Abbondanza Pantaleo,Annalisa Astolfiet al. OncoImmunology, 2015, 4 (5), pp.e1002729. ⟨10.1080/2162402X.2014.1002729⟩ Article dans une revue hal-03583480v1
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial Patricia Pautier,Anne Floquet,Christine Chevreau,Nicolas Penel,Cécile Guillemetet al. Lancet Oncology, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩ Article dans une revue istex hal-03623745v1
The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy François Bertucci,Pascal Finetti,Daniel Birnbaum Breast Cancer Research, 2015, 17 (1), pp.54. ⟨10.1186/s13058-015-0559-2⟩ Article dans une revue hal-03623743v1
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a Adam Wolfe,Bisrat Debeb,Lara Lacerda,Richard Larson,Arvind Bambhroliyaet al. Breast Cancer Research and Treatment, 2015, 154 (3), pp.495-508. ⟨10.1007/s10549-015-3645-3⟩ Article dans une revue hal-03623740v1
NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib Léo Aubert,Matthieu Guilbert,Cyril Corbet,Elisabeth Génot,Eric Adriaenssenset al. Oncotarget, 2015, 6 (12), pp.9807-9819. ⟨10.18632/oncotarget.3227⟩ Article dans une revue hal-03623750v1
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer Jennifer Allensworth,Myron Evans,François Bertucci,Amy Aldrich,Richard Festaet al. Molecular Oncology, 2015, 9 (6), pp.1155-1168. ⟨10.1016/j.molonc.2015.02.007⟩ Article dans une revue hal-03623746v1
Prognostic and predictive value of PDL1 expression in breast cancer Renaud Sabatier,Pascal Finetti,Emilie Mamessier,José Adelaide,Max Chaffanetet al. Oncotarget, 2015, 6 (7), pp.5449-5464. ⟨10.18632/oncotarget.3216⟩ Article dans une revue hal-03583484v1
Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancer Andrea Remo,Ines Simeone,Massimo Pancione,Pietro Parcesepe,Pascal Finettiet al. Journal of Translational Medicine, 2015, 13 (1), pp.138. ⟨10.1186/s12967-015-0492-2⟩ Article dans une revue inserm-01264508v1
BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients A Laroche-Clary,V Chaire,V Le Morvan,A. Neuville,F. Bertucciet al. British Journal of Cancer, 2015, 112 (4), pp.688-692. ⟨10.1038/bjc.2014.624⟩ Article dans une revue hal-02277467v1
PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy François Bertucci,Pascal Finetti,Cécile Colpaert,Emilie Mamessier,Maxime Parizelet al. Oncotarget, 2015, 6 (15), pp.13506-13519. ⟨10.18632/oncotarget.3642⟩ Article dans une revue hal-03583483v1
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial Axel Le Cesne,Jean-Yves Blay,Julien Domont,Emmanuelle Tresch-Bruneel,Christine Chevreauet al. Lancet Oncology, 2015, 16 (3), pp.312-319. ⟨10.1016/s1470-2045(15)70031-8⟩ Article dans une revue istex hal-03623747v1
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial Isabelle Ray-Coquard,Julien Domont,Emmanuelle Tresch-Bruneel,Emmanuelle Bompas,Philippe Cassieret al. Journal of Clinical Oncology, 2015, 33 (25), pp.2797-2802. ⟨10.1200/jco.2015.60.8505⟩ Article dans une revue hal-03623742v1
Guideline sheets on the side effects of anticancer drugs are useful for general practitioners Marie-Eve Rouge-Bugat,Donia Lassoued,Joy Bacrie,Nathalie Boussier,Jean-Pierre Delordet al. Supportive Care in Cancer, 2015, pp.3473 - 3480. ⟨10.1007/s00520-015-2705-x⟩ Article dans une revue hal-01914751v1
Brief Reports: A Distinct DNA Methylation Signature Defines Breast Cancer Stem Cells and Predicts Cancer Outcome Rita El Helou,Julien Wicinski,Arnaud Guille,José Adelaïde,Pascal Finettiet al. STEM CELLS, 2014, 32 (11), pp.3031-3036. ⟨10.1002/stem.1792⟩ Article dans une revue hal-01431934v1
Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling Stéphanie Cornen,Arnaud Guille,José Adelaïde,Lynda Addou-Klouche,Pascal Finettiet al. PLoS ONE, 2014, 9 (1), pp.e81843. ⟨10.1371/journal.pone.0081843⟩ Article dans une revue hal-01614950v1
EFA6B Antagonizes Breast Cancer Joséphine Zangari,Mariagrazia Partisani,François Bertucci,Julie Milanini,Ghislain Bidautet al. Cancer Research, 2014, 74 (19), pp.5493-5506. ⟨10.1158/0008-5472.can-14-0298⟩ Article dans une revue hal-03623755v1
Personalized medicine: Present and future of breast cancer management Renaud Sabatier,Anthony Gonçalves,François Bertucci Critical Reviews in Oncology/Hematology, 2014, 91 (3), pp.223-233. ⟨10.1016/j.critrevonc.2014.03.002⟩ Article dans une revue hal-03623758v1
Genomic profiling of inflammatory breast cancer: A review François Bertucci,Pascal Finetti,Peter Vermeulen,Peter van Dam,Luc Dirixet al. The Breast, 2014, 23 (5), pp.538-545. ⟨10.1016/j.breast.2014.06.008⟩ Article dans une revue hal-03623757v1
Traitements systémiques des cancers du sein inflammatoires : un état des lieux Audrey Monneur,François Bertucci,Patrice Viens,Anthony Gonçalves Bulletin du Cancer, 2014, 101 (12), pp.1080-1088. ⟨10.1684/bdc.2014.2014⟩ Article dans une revue hal-03623752v1
Alterations of polycomb gene BMI1 in human myeloproliferative neoplasms Mandy Brecqueville,José Adélaïde,François Bertucci,Pascal Finetti,Max Chaffanetet al. Cell Cycle, 2014, 11 (16), pp.3141-3142. ⟨10.4161/cc.21114⟩ Article dans une revue hal-03623775v1
Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib Marine Gilabert,Simon Launay,Christophe Ginestier,François Bertucci,Stéphane Audebertet al. PLoS ONE, 2014, 9 (8), pp.e104302. ⟨10.1371/journal.pone.0104302⟩ Article dans une revue hal-01431935v1
EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer François Bertucci,Pascal Finetti,Patrice Viens,Daniel Birnbaum Cancer Letters, 2014, 355 (1), pp.70-75. ⟨10.1016/j.canlet.2014.09.014⟩ Article dans une revue hal-03623754v1
Primary Synovial Sarcoma of the Thyroid Gland: Case Report and Review of the Literature Laurys Boudin,Nicolas Fakhry,Bruno Chetaille,Delphine Perrot,Anh Tuan Nguyenet al. Case Reports in Oncology, 2014, 7 (1), pp.6-13. ⟨10.1159/000357913⟩ Article dans une revue hal-03623760v1
The off-label use of targeted therapies in sarcomas: the OUTC’S program Lauriane Eberst,Claire Cropet,Axel Le Cesne,Patricia Pautier,Nicolas Penelet al. BMC Cancer, 2014, 14 (1), pp.870. ⟨10.1186/1471-2407-14-870⟩ Article dans une revue hal-03623753v1
Stealth&quot; tumors: Breast cancer cells shun NK-cells anti-tumor immunity Emilie Mamessier,François Bertucci,Renaud Sabatier,Daniel Birnbaum,Daniel Olive OncoImmunology, 2014, 1 (3), pp.366-368. ⟨10.4161/onci.18528⟩ Article dans une revue hal-03583489v1
The CINSARC signature: Prognostic and predictive of response to chemotherapy? François Bertucci,Pascal Finetti,Renaud Sabatier,Daniel Birnbaum Cell Cycle, 2014, 9 (19), pp.4025-4027. ⟨10.4161/cc.9.19.13463⟩ Article dans une revue hal-03623803v1
Characterization of S628N: a novel KIT mutation found in a metastatic melanoma Marina Vita,Julie C Tisserand,Isaure Chauvot de Beauchêne,Nicolas Panel,Luba Tchertanovet al. JAMA Dermatology, 2014, 150 (12), ⟨10.1001/jamadermatol.2014.1437⟩ Article dans une revue hal-01505849v1
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization Renaud Sabatier,Pascal Finetti,Arnaud Guille,José Adelaïde,Max Chaffanetet al. Molecular Cancer, 2014, 13, pp.228. ⟨10.2174/156652412798376134⟩ Article dans une revue inserm-01192813v1
The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets. Maria Katsogiannou,Claudia Andrieu,Virginie Baylot,Anaïs Baudot,Nelson J Dusettiet al. Molecular and Cellular Proteomics, 2014, pp.3585-601. ⟨10.1074/mcp.M114.041228⟩ Article dans une revue hal-01104661v1
ESPL1 is a candidate oncogene of luminal B breast cancers Pascal Finetti,Arnaud Guille,José Adelaide,Daniel Birnbaum,Max Chaffanetet al. Breast Cancer Research and Treatment, 2014, 147 (1), pp.51-59. ⟨10.1007/s10549-014-3070-z⟩ Article dans une revue hal-03623756v1
Genomic and expression analysis of microdissected inflammatory breast cancer Wendy Woodward,Savitri Krishnamurthy,Hideko Yamauchi,Randa El-Zein,Dai Oguraet al. Breast Cancer Research and Treatment, 2013, 138 (3), pp.761-772. ⟨10.1007/s10549-013-2501-6⟩ Article dans une revue hal-03623767v1
Dramatic and Delayed Response to Doxorubicin-Dacarbazine Chemotherapy of a Giant Desmoid Tumor: Case Report and Literature Review Audrey Monneur,Bruno Chetaille,Delphine Perrot,Jérôme Guiramand,François Bertucci Case Reports in Oncology, 2013, 6 (1), pp.127-133. ⟨10.1159/000349918⟩ Article dans une revue hal-03623771v1
ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program Emmanuelle Charafe-Jauffret,Christophe Ginestier,François Bertucci,Olivier Cabaud,Julien Wicinskiet al. Cancer Research, 2013, 73 (24), pp.7290-7300. ⟨10.1158/0008-5472.CAN-12-4704⟩ Article dans une revue hal-01431937v1
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study Corinne Bouvier,François Bertucci,Philippe Métellus,Pascal Finetti,André Maues de Paulaet al. Acta Neuropathologica Communications, 2013, 1 (1), pp.10 Article dans une revue inserm-00837790v1
Médecine personnalisée et cancer du sein : médecine anticipatoire, évaluation pronostique et ciblage thérapeutique Anthony Gonçalves,Jessica Moretta,François Eisinger,François Bertucci Bulletin du Cancer, 2013, 100 (12), pp.1295-1310. ⟨10.1684/bdc.2013.1856⟩ Article dans une revue hal-03623762v1
Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets Emilie Mamessier,C. Pradel,M.-L. Thibult,C. Drevet,A. Zouineet al. Journal of Immunology, 2013, 190 (5), pp.2424 - 2436. ⟨10.4049/jimmunol.1200140⟩ Article dans une revue hal-01765648v1
Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets Steven van Laere,Naoto Ueno,Pascal Finetti,Peter Vermeulen,Anthony Lucciet al. Clinical Cancer Research, 2013, 19 (17), pp.4685-4696. ⟨10.1158/1078-0432.ccr-12-2549⟩ Article dans une revue hal-03623770v1
Cancer du sein triple-négatif : caractéristiques histocliniques et moléculaires, prise en charge et perspectives thérapeutiques Anthony Gonçalves,Renaud Sabatier,Emmanuelle Charafe-Jauffret,Marine Gilabert,Magali Provansalet al. Bulletin du Cancer, 2013, 100 (5), pp.453-464. ⟨10.1684/bdc.2013.1740⟩ Article dans une revue hal-03623766v1
Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets E. Mamessier,Lydie Pradel,M.-L. Thibult,C. Drevet,A. Zouineet al. Journal of Immunology, 2013, 190 (5), pp.2424--2436. ⟨10.4049/jimmunol.1200140⟩ Article dans une revue hal-01612099v1
Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma Laurence Moureau-Zabotto,Olivier Turrini,Michel Resbeut,Jean-Luc Raoul,Marc Giovanniniet al. BMC Cancer, 2013, 13 (1), pp.568. ⟨10.1186/1471-2407-13-568⟩ Article dans une revue hal-03623761v1
Gene Expression Profiling of Solitary Fibrous Tumors François Bertucci,Corinne Bouvier-Labit,Pascal Finetti,Philippe Metellus,José Adelaïdeet al. PLoS ONE, 2013, 8 (5), pp.e64497. ⟨10.1371/journal.pone.0064497⟩ Article dans une revue hal-01537869v1
Presence of anaplastic lymphoma kinase in inflammatory breast cancer Fredika Robertson,Emanuel Petricoin Iii,Steven van Laere,François Bertucci,Khoi Chuet al. SpringerPlus, 2013, 2 (1), pp.497. ⟨10.1186/2193-1801-2-497⟩ Article dans une revue hal-03623764v1
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers Hiroko Masuda,Keith Baggerly,Ying Wang,Takayuki Iwamoto,Takae Breweret al. Breast Cancer Research, 2013, 15 (6), pp.R112. ⟨10.1186/bcr3579⟩ Article dans une revue hal-03623763v1
Difference in Therapeutic Response Between Basal and Nonbasal Triple-Negative Breast Cancers François Bertucci,Pascal Finetti,Patrice Viens,Daniel Birnbaum Oncologist, 2013, 18 (9), pp.1060-1061. ⟨10.1634/theoncologist.2013-0121⟩ Article dans une revue hal-03623765v1
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts V. Gelsi-Boyer,N. Cervera,François Bertucci,M. Brecqueville,P. Finettiet al. Haematologica, 2013, 98 (4), pp.576-583. ⟨10.3324/haematol.2012.071506⟩ Article dans une revue hal-03623773v1
The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression Marion A. Salvador,Julien Wicinski,Olivier Cabaud,Yves Toiron,Pascal Finettiet al. Clinical Cancer Research, 2013, 19 (23), pp.6520-6531. ⟨10.1158/1078-0432.CCR-13-0877⟩ Article dans une revue hal-01431936v1
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program Jean-Yves Blay,Antoine Italiano,Isabelle Ray-Coquard,Axel Le Cesne,Florence Duffaudet al. BMC Cancer, 2013, 13 (1), pp.64. ⟨10.1186/1471-2407-13-64⟩ Article dans une revue hal-03623768v1
Comprehensive genome characterization of solitary fibrous tumors using high‐resolution array‐based comparative genomic hybridization François Bertucci,Corinne Bouvier‐labit,Pascal Finetti,José Adélaïde,Philippe Metelluset al. Genes, Chromosomes & Cancer, 2013, 52 (2), pp.156-164. ⟨10.1002/gcc.22015⟩ Article dans une revue istex hal-03623772v1
Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era Philippe Cassier,Elena Fumagalli,Piotr Rutkowski,Patrick Schöffski,Martine van Glabbekeet al. Clinical Cancer Research, 2012, 18 (16), pp.4458-4464. ⟨10.1158/1078-0432.ccr-11-3025⟩ Article dans une revue hal-03623776v1
Contrasted outcomes to gefitinib on tumoral IGF1R expression in head and neck cancer patients receiving postoperative chemoradiation (GORTEC trial 2004-02). Juliette Thariat,René-Jean Bensadoun,Marie-Christine Etienne-Grimaldi,Dominique Grall,Frédérique Penault-Llorcaet al. Clinical Cancer Research, 2012, 18 (18), pp.5123-33. ⟨10.1158/1078-0432.CCR-12-1518⟩ Article dans une revue hal-00770510v1
Are there candidates for high-dose chemotherapy in ovarian carcinoma? Renaud Sabatier,Anthony Gonçalves,François Bertucci,Maria-Antonietta Capiello,Frédérique Rousseauet al. Journal of Experimental and Clinical Cancer Research, 2012, 31 (1), pp.87. ⟨10.1186/1756-9966-31-87⟩ Article dans une revue inserm-00765646v1
Breast Metastasis of a Squamous Cell Carcinoma of the Uterine Cervix Mimicking Inflammatory Breast Cancer Renaud Sabatier,Céline Roussin,Jean-Pierre Riviere,Aurélie Jalaguier,Jocelyne Jacquemieret al. Case Reports in Oncology, 2012, 5 (2), pp.464-470. ⟨10.1159/000342255⟩ Article dans une revue hal-03623778v1
Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur Isabelle Pellegrini,Myrto Rapti,Jean-Marc Extra,Anouk Petri-Cal,Themis Apostolidiset al. Médecine/Sciences, 2012, 28, pp.24-27. ⟨10.1051/medsci/2012281s107⟩ Article dans une revue hal-03623782v1
Génomique et recherche clinique en cancérologie mammaire François Bertucci,Daniel Birnbaum Médecine/Sciences, 2012, 28, pp.14-18. ⟨10.1051/medsci/2012281s105⟩ Article dans une revue hal-03623780v1
Interactome-Transcriptome integration for predicting distant metastasis in breast cancer Maxime Garcia,Raphaelle Millat-Carus,François Bertucci,Pascal Finetti,Daniel Birnbaumet al. Bioinformatics, 2012, 28 (5), pp.672-678. ⟨10.1093/bioinformatics/bts025⟩ Article dans une revue hal-01784470v1
A refined molecular taxonomy of breast cancer. Michael Guedj,Laëtitia Marisa,Aurélien de Reynies,Béatrice Orsetti,Renaud Schiappaet al. Oncogene, 2012, 31 (9), pp.1196-206. ⟨10.1038/onc.2011.301⟩ Article dans une revue inserm-00611752v1
Solitary Fibrous Tumor in the Round Ligament of the Liver: A Fortunate Intraoperative Discovery Laura Beyer,Jean-Robert Delpero,Bruno Chetaille,Anthony Sarran,Delphine Perrotet al. Case Reports in Oncology, 2012, 5 (1), pp.187-194. ⟨10.1159/000338616⟩ Article dans une revue hal-03623784v1
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma Jocelyne Jacquemier,François Bertucci,Pascal Finetti,Benjamin Esterni,Emmanuelle Charafe-Jauffretet al. International Journal of Cancer, 2012, 130 (1), pp.96-104. ⟨10.1002/ijc.25979⟩ Article dans une revue hal-03623783v1
Pancreatic metastasis from osteosarcoma and Ewing sarcoma: literature review François Bertucci,Julia Araujo,Marc Giovannini Scandinavian Journal of Gastroenterology, 2012, 48 (1), pp.4-8. ⟨10.3109/00365521.2012.711852⟩ Article dans une revue hal-03623774v1
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas Antoine Italiano,Angela Cioffi,Nicolas Penel,Matteo Giaj Levra,Corinne Delcambreet al. Cancer, 2012, 118 (13), pp.3330-3336. ⟨10.1002/cncr.26599⟩ Article dans une revue hal-03623788v1
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors. Antoine Adenis,Olivier Bouché,François Bertucci,Elsa Kalbacher,Charles Fournieret al. Medical oncology and tumor pharmacotherapy, 2012, 29 (4), pp.3003-8. ⟨10.1007/s12032-012-0204-1⟩ Article dans une revue istex hal-00850693v1
Tests diagnostiques et thérapies ciblées en cancérologie Patricia Marino,François Bertucci,Anthony Gonçalves,Valérie Seror Médecine/Sciences, 2012, 28, pp.19-23. ⟨10.1051/medsci/2012281s106⟩ Article dans une revue hal-03623781v1
Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents Gais Kadra,Pascal Finetti,Yves Toiron,Patrice Viens,Daniel Birnbaumet al. Breast Cancer Research and Treatment, 2012, 132 (3), pp.1035-1047. ⟨10.1007/s10549-011-1687-8⟩ Article dans une revue istex hal-03623793v1
Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis. J. Gillibert-Duplantier,B. Duthey,V. Sisirak,D. Salaün,T. Gargiet al. Oncogene, 2012, 31 (30), pp.3516-24. ⟨10.1038/onc.2011.525⟩ Article dans une revue hal-00820060v1
Solitary Fibrous Tumor of the Prostate: Case Report and Review of the Literature Laurence Moureau-Zabotto,Bruno Chetaille,Franck Bladou,Pierre-Yves Dauvergne,Myriam Marcyet al. Case Reports in Oncology, 2012, 5 (1), pp.22-29. ⟨10.1159/000335680⟩ Article dans une revue hal-03623785v1
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms Mandy Brecqueville,Jérôme Rey,François Bertucci,Emilie Coppin,Pascal Finettiet al. Genes, Chromosomes & Cancer, 2012, 51 (8), pp.743-755. ⟨10.1002/gcc.21960⟩ Article dans une revue istex hal-03623779v1
Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target Christophe Ginestier,Florence Monville,Julien Wicinski,Olivier Cabaud,Nathalie Cerveraet al. STEM CELLS, 2012, 30 (7), pp.1327-1337. ⟨10.1002/stem.1122⟩ Article dans une revue hal-01431941v1
8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer François Bertucci,Arnaud Lagarde,Anthony Ferrari,Pascal Finetti,Emmanuelle Charafe-Jauffretet al. PLoS ONE, 2012, 7 (5), pp.e37943. ⟨10.1371/journal.pone.0037943⟩ Article dans une revue hal-03623777v1
Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer Renaud Sabatier,Pascal Finetti,José Adelaide,Arnaud Guille,Jean-Paul Borget al. PLoS ONE, 2011, 6 (11), pp.e27656. ⟨10.1371/journal.pone.0027656⟩ Article dans une revue hal-03623789v1
Endometriosis-Associated Ovarian Carcinomas François Bertucci New England Journal of Medicine, 2011, 364 (5), pp.482-485. ⟨10.1056/nejmc1012780⟩ Article dans une revue hal-03623797v1
Kinome expression profiling and prognosis of basal breast cancers Renaud Sabatier,Pascal Finetti,Emilie Mamessier,Stéphane Raynaud,Nathalie Cerveraet al. Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩ Article dans une revue hal-03606422v1
Characterisation of Genome-Wide PLZF/RARA Target Genes Salvatore Spicuglia,Christelle Vincent-Fabert,Touati Benoukraf,Guillaume Tibéri,Andrew J Saurinet al. PLoS ONE, 2011, 6 (9), pp.e24176. ⟨10.1371/journal.pone.0024176⟩ Article dans une revue hal-00674513v1
Gene Expression Profiling for In Silico Microdissection of Hodgkin's Lymphoma Microenvironment and Identification of Prognostic Features François Bertucci,Bruno Chetaille,Luc Xerri Advances in Hematology, 2011, 2011, pp.1-8. ⟨10.1155/2011/485310⟩ Article dans une revue hal-03623801v1
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. Aurore Blesius,Philippe Cassier,François Bertucci,Jérome Fayette,Isabelle Ray-Coquardet al. BMC Cancer, 2011, 11, pp.72. ⟨10.1186/1471-2407-11-72⟩ Article dans une revue hal-00779604v1
Kinome expression profiling and prognosis of basal breast cancers. Renaud Sabatier,Pascal Finetti,Emilie Mamessier,Stéphane Raynaud,Nathalie Cerveraet al. Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩ Article dans une revue inserm-00614833v1
High incidence of asymptomatic renal cancer in late survivors after heart transplantation Pierre Ambrosi,François Bertucci,Bernard Kreitmann The Journal of Heart and Lung Transplantation, 2011, 30 (10), pp.1202-1203. ⟨10.1016/j.healun.2011.05.003⟩ Article dans une revue hal-03623795v1
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial. Jocelyne Jacquemier,Jean-Marie Boher,Henri Roche,Benjamin Esterni,Daniel Serinet al. Breast Cancer Research, 2011, 13 (6), pp.R109. ⟨10.1186/bcr3051⟩ Article dans une revue inserm-00647247v1
Primary leiomyosarcoma of the seminal vesicle: Case report and review of the literature Cécile Cauvin,Laurence Moureau-Zabotto,Bruno Chetaille,Werner Hilgers,Yves Denouxet al. BMC Cancer, 2011, 11 (1), pp.323. ⟨10.1186/1471-2407-11-323⟩ Article dans une revue hal-03623794v1
Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review Simon Launay,Bruno Chetaille,Fanny Medina,Delphine Perrot,Serge Nazarianet al. BMC Cancer, 2011, 11 (1), pp.423. ⟨10.1186/1471-2407-11-423⟩ Article dans une revue hal-03623791v1
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer Fabrice Sircoulomb,Nathalie Nicolas,Anthony Ferrari,Pascal Finetti,Ismahane Bekhoucheet al. EMBO Molecular Medicine, 2011, 3 (3), pp.153-166. ⟨10.1002/emmm.201100121⟩ Article dans une revue hal-01431945v1
Peritumoural vascular invasion: A major determinant of triple-negative breast cancer outcome Renaud Sabatier,Jocelyne Jacquemier,François Bertucci,Benjamin Esterni,Pascal Finettiet al. European Journal of Cancer, 2011, 47 (10), pp.1537-1545. ⟨10.1016/j.ejca.2011.02.002⟩ Article dans une revue istex hal-03623796v1
Planification systématique de l'apprentissage hospitalier de la cancérologie par les étudiants en DCEM Anthony Gonçalves,Patrice Viens,Marine Gilabert,Olivier Turrini,Éric Lambaudieet al. Bulletin du Cancer, 2011, 98 (12), pp.1489-1508. ⟨10.1684/bdc.2011.1504⟩ Article dans une revue hal-03623787v1
Clinical Application of Proteomics in Breast Cancer: State of the Art and Perspectives Anthony Goncalves,François Bertucci Medical Principles and Practice, 2011, 20 (1), pp.4-18. ⟨10.1159/000319544⟩ Article dans une revue hal-03623800v1
CD47–signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction Xi Wen Zhao,Ellen van Beek,Karin Schornagel,Hans van Der Maaden,Michel van Houdtet al. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108 (45), pp.18342-18347. ⟨10.1073/pnas.1106550108⟩ Article dans une revue hal-03623790v1
High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes Ismahane Bekhouche,Pascal Finetti,José Adelaïde,Anthony Ferrari,Carole Tarpinet al. PLoS ONE, 2011, 6 (2), pp.e16950. ⟨10.1371/journal.pone.0016950⟩ Article dans une revue hal-03623798v1
Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition Emilie Mamessier,A. Sylvain,F. Bertucci,R. Castellano,P. Finettiet al. Cancer Research, 2011, 71 (21), pp.6621 - 6632. ⟨10.1158/0008-5472.CAN-11-0792⟩ Article dans une revue hal-01765652v1
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity Emilie Mamessier,Aude Sylvain,Marie-Laure Thibult,Gilles Houvenaeghel,Jocelyne Jacquemieret al. Journal of Clinical Investigation, 2011, 121 (9), pp.3609 - 3622. ⟨10.1172/JCI45816⟩ Article dans une revue hal-01765654v1
mRNA expression in human breast cancer: a meta-analysis Anthony Gonçalves,Pascal Finetti,Renaud Sabatier,Marine Gilabert,José Adelaïdeet al. Breast Cancer Research and Treatment, 2010, 127 (1), pp.273-281. ⟨10.1007/s10549-010-1199-y⟩ Article dans une revue hal-00594471v1
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer François Bertucci,Nathalie Borie,Henri Roche,Thomas Bachelot,Jean-Marc Doussalet al. Breast Cancer Research and Treatment, 2010, 127 (2), pp.363-373. ⟨10.1007/s10549-010-1003-z⟩ Article dans une revue hal-00594464v1
A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia Hugues de Lavallade,Pascal Finetti,Nadine Carbuccia,Jamshid Khorashad,Aude Charbonnieret al. Leukemia Research, 2010, 34 (2), pp.254-257. ⟨10.1016/j.leukres.2009.09.026⟩ Article dans une revue istex hal-03623812v1
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer Emmanuelle Charafe-Jauffret,Christophe Ginestier,Flora Iovino,Carole Tarpin,Mark Diebelet al. Clinical Cancer Research, 2010, 16 (1), pp.45-55. ⟨10.1158/1078-0432.CCR-09-1630⟩ Article dans une revue hal-01431949v1
A gene expression signature identifies two prognostic subgroups of basal breast cancer Renaud Sabatier,Pascal Finetti,Nathalie Cervera,Eric Lambaudie,Benjamin Esterniet al. Breast Cancer Research and Treatment, 2010, 126 (2), pp.407-420. ⟨10.1007/s10549-010-0897-9⟩ Article dans une revue hal-00583558v1
Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies Patrice Viens,Carole Tarpin,Henri Roche,François Bertucci Cancer, 2010, 116 (S11), pp.2829-2836. ⟨10.1002/cncr.25168⟩ Article dans une revue hal-03623807v1
Gene expression profiling of inflammatory breast cancer François Bertucci,Pascal Finetti,Daniel Birnbaum,Patrice Viens Cancer, 2010, 116 (S11), pp.2783-2793. ⟨10.1002/cncr.25165⟩ Article dans une revue hal-03623806v1
Economic issues involved in integrating genomic testing into clinical care: the case of genomic testing to guide decision-making about chemotherapy for breast cancer patients Patricia Marino,Carole Siani,François Bertucci,Henri Roche,Anne-Laure Martinet al. Breast Cancer Research and Treatment, 2010, 129 (2), pp.401-409. ⟨10.1007/s10549-010-1242-z⟩ Article dans une revue hal-00615386v1
Low-grade extraskeletal osteosarcoma of the chest wall: case report and review of literature. Renaud Sabatier,Corinne Bouvier,Gonzague de Pinieux,Anthony Sarran,Isabelle Brenot-Rossiet al. BMC Cancer, 2010, 10, pp.645. ⟨10.1186/1471-2407-10-645⟩ Article dans une revue hal-00546735v1
Pediatric mastocytosis–associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations Ying Yang,Sébastien Létard,Laurence Borge,Amandine Chaix,Katia Hanssenset al. Blood, 2010, 116 (7), pp.1114-1123. ⟨10.1182/blood-2009-06-226027⟩ Article dans une revue hal-03623808v1
Genome profiling of ERBB2-amplified breast cancers Fabrice Sircoulomb,Ismahane Bekhouche,Pascal Finetti,José Adélaïde,Azza Ben Hamidaet al. BMC Cancer, 2010, 10 (1), pp.539. ⟨10.1186/1471-2407-10-539⟩ Article dans une revue hal-03623802v1
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer Renaud Sabatier,José Adélaïde,Pascal Finetti,Anthony Ferrari,Laetitia Huiartet al. Genes, Chromosomes & Cancer, 2010, 49 (12), pp.1143-1151. ⟨10.1002/gcc.20822⟩ Article dans une revue istex hal-03623799v1
Une forme « ariditaire » du cancer de l’ovaire David Birnbaum,Renaud Sabatier,Emilie Mamessier,Daniel Birnbaum,François Bertucci Médecine/Sciences, 2010, 26 (12), pp.1040-1042. ⟨10.1051/medsci/201026121040⟩ Article dans une revue hal-03583491v1
Meningeal chondroblastic osteosarcoma: case report and review of the literature Emilie Romeo,Olivier Gisserot,Jean-Pierre de Jaureguiberry,Nicolas Desse,Jean-Baptiste Souraudet al. Journal of Neuro-Oncology, 2010, 100 (2), pp.305-309. ⟨10.1007/s11060-010-0167-z⟩ Article dans une revue istex hal-03623809v1
Masitinib combined with standard Gemcitabine chemotherapy : in vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model M. Humbert,N. Casteran,S. Letard,K. Hanssens,J. Iovannaet al. PLoS ONE, 2010, 5 (3), pp.e9430-e9437. ⟨10.1371/journal.pone.0009430⟩ Article dans une revue hal-00473110v1
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial Axel Le Cesne,Isabelle Ray-Coquard,Binh Nguyen Bui,Antoine Adenis,Maria Rioset al. Lancet Oncology, 2010, 11 (10), pp.942-949. ⟨10.1016/s1470-2045(10)70222-9⟩ Article dans une revue istex hal-03623804v1
Protéomique et cancer du sein : à la recherche de nouveaux biomarqueurs diagnostiques et théragnostiques Marine Gilabert,Stéphane Audebert,Patrice Viens,Jean-Paul Borg,François Bertucciet al. Bulletin du Cancer, 2010, 97 (3), pp.321-339. ⟨10.1684/bdc.2010.1061⟩ Article dans une revue hal-03623810v1
Loss, mutation and deregulation of L3MBTL4 in breast cancers Lynda Addou-Klouche,José Adélaïde,Pascal Finetti,Nathalie Cervera,Anthony Ferrariet al. Molecular Cancer, 2010, 9 (1), pp.213. ⟨10.1186/1476-4598-9-213⟩ Article dans une revue hal-03623805v1
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines Gwladys Zabouo,Anne-Marie Imbert,Jocelyne Jacquemier,Pascal Finetti,Thomas Moreauet al. Breast Cancer Research, 2009, 11 (1), pp.R1. ⟨10.1186/bcr2215⟩ Article dans une revue hal-03623818v1
Distant metastasis: not out of reach any more François Bertucci,Daniel Birnbaum Journal of Biology, 2009, 8 (3), pp.28. ⟨10.1186/jbiol128⟩ Article dans une revue hal-03623815v1
Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status Anthony Gonçalves,Mathilde Deblock,Benjamin Esterni,Carole Tarpin,François Bertucciet al. Anti-Cancer Drugs, 2009, 20 (10), pp.946-952. ⟨10.1097/cad.0b013e328331178f⟩ Article dans une revue hal-03623811v1
Gene Expression Profiles as Predictors of Poor Outcomes in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis An-Ting Lu,Shelley Salpeter,Anthony Reeve,Steven Eschrich,Patrick Johnstonet al. Clinical Colorectal Cancer, 2009, 8 (4), pp.207-214. ⟨10.3816/ccc.2009.n.035⟩ Article dans une revue hal-03623813v1
Gene expression profiling and prediction of clinical outcome in ovarian cancer Renaud Sabatier,Pascal Finetti,Nathalie Cervera,Daniel Birnbaum,François Bertucci Critical Reviews in Oncology/Hematology, 2009, 72 (2), pp.98-109. ⟨10.1016/j.critrevonc.2009.01.007⟩ Article dans une revue istex hal-03623817v1
Retinoid signaling regulates breast cancer stem cell differentiation Christophe Ginestier,Julien Wicinski,Nathalie Cervera,Florence Monville,Pascal Finettiet al. Cell Cycle, 2009, 8 (20), pp.3297-3302. ⟨10.4161/cc.8.20.9761⟩ Article dans une revue hal-01431955v1
How different are luminal A and basal breast cancers? François Bertucci,Pascal Finetti,Nathalie Cervera,Emmanuelle Charafe-Jauffret,Max Buttarelliet al. International Journal of Cancer, 2009, 124 (6), pp.1338-1348. ⟨10.1002/ijc.24055⟩ Article dans une revue hal-03623816v1
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome Bruno Chetaille,François Bertucci,Pascal Finetti,Benjamin Esterni,Aspasia Stamatoullaset al. Blood, 2009, 113 (12), pp.2765-3775. ⟨10.1182/blood-2008-07-168096⟩ Article dans une revue hal-03623820v1
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature Emmanuelle Charafe-Jauffret,Christophe Ginestier,Flora Iovino,Julien Wicinski,Nathalie Cerveraet al. Cancer Research, 2009, 69 (4), pp.1302-1313. ⟨10.1158/0008-5472.CAN-08-2741⟩ Article dans une revue hal-01431954v1
Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer Jocelyne Jacquemier,Emmanuelle Charafe-Jauffret,Florence Monville,Benjamin Esterni,Jean Marc Extraet al. Breast Cancer Research, 2009, 11 (2), pp.R23. ⟨10.1186/bcr2249⟩ Article dans une revue hal-03623814v1
Defining the Molecular Biology of Inflammatory Breast Cancer Emmanuelle Charafe-Jauffret,Carole Tarpin,Patrice Viens,François Bertucci Seminars in Oncology, 2008, 35 (1), pp.41-50. ⟨10.1053/j.seminoncol.2007.11.015⟩ Article dans une revue hal-03623825v1
A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment Anthony Gonçalves,Séverine Esteyries,Brynn Taylor-Smedra,Arnaud Lagarde,Mounay Ayadiet al. BMC Cancer, 2008, 8 (1), pp.169. ⟨10.1186/1471-2407-8-169⟩ Article dans une revue hal-03623821v1
Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis Pascal Finetti,Nathalie Cervera,Emmanuelle Charafe-Jauffret,Christian Chabannon,Colette Charpinet al. Cancer Research, 2008, 68 (3), pp.767-776. ⟨10.1158/0008-5472.can-07-5516⟩ Article dans une revue hal-03623826v1
Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin Azza Ben Hamida,Intidhar Labidi,Karima Mrad,Emmanuelle Charafe-Jauffret,Saïda Ben Arabet al. BMC Cancer, 2008, 8 (1), pp.28. ⟨10.1186/1471-2407-8-28⟩ Article dans une revue hal-03623827v1
Classification pronostique du cancer du sein et profils d’expression génique sur puces à ADN François Bertucci,Pascal Finetti,Nathalie Cervera,Daniel Birnbaum Médecine/Sciences, 2008, 24 (6-7), pp.599-606. ⟨10.1051/medsci/20082467599⟩ Article dans une revue hal-03623822v1
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. François Bertucci,Béatrice Orsetti,Vincent Nègre,Pascal Finetti,Carole Rougéet al. Oncogene, 2008, 27 (40), pp.5359-72. ⟨10.1038/onc.2008.158⟩ Article dans une revue inserm-00290484v1
Stem cells and epithelial cancers: the example of breast cancer Emanuelle Charafe-Jauffret,Christophe Ginestier,Florence Monville,Julien Wicinski,François Bertucciet al. Annales de Pathologie, 2008, 28, pp.S30-S32. ⟨10.1016/j.annpat.2008.09.005⟩ Article dans une revue hal-01431960v1
Absence of ESR1 amplification in a series of breast cancers José Adélaïde,Pascal Finetti,Emmanuelle Charafe-Jauffret,Julien Wicinski,Jocelyne Jacquemieret al. International Journal of Cancer, 2008, 123 (12), pp.2970-2972. ⟨10.1002/ijc.23786⟩ Article dans une revue hal-03623819v1
Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery François Bertucci,Anthony Goncalves Future Oncology, 2008, 4 (2), pp.271-287. ⟨10.2217/14796694.4.2.271⟩ Article dans une revue hal-03623823v1
How basal are triple-negative breast cancers? F. Bertucci,Pascal Finetti,Nathalie Cervera,Benjamin Esterni,Fabienne Hermitteet al. International Journal of Cancer, 2008, 123 (1), pp.236-240. ⟨10.1002/ijc.23518⟩ Article dans une revue hal-03623624v1
Reasons for breast cancer heterogeneity François Bertucci,Daniel Birnbaum Journal of Biology, 2008, 7 (2), pp.6. ⟨10.1186/jbiol67⟩ Article dans une revue hal-03623828v1
Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers Associated with Molecular Subtypes Anthony Goncçalves,Emmanuelle Charafe-Jauffret,François Bertucci,Stéphane Audebert,Yves Toironet al. Molecular and Cellular Proteomics, 2008, 7 (8), pp.1420-1433. ⟨10.1074/mcp.m700487-mcp200⟩ Article dans une revue hal-03623824v1
Moesin expression is a marker of basal breast carcinomas Emmanuelle Charafe-Jauffret,Florence Monville,Francois Bertucci',Benjamin Esterni,Christophe Ginestieret al. International Journal of Cancer, 2007, 121 (8), pp.1779-1785. ⟨10.1002/ijc.22923⟩ Article dans une revue hal-01431969v1
Integrated Profiling of Basal and Luminal Breast Cancers J. Adelaide,P. Finetti,I. Bekhouche,L. Repellini,J. Geneixet al. Cancer Research, 2007, 67 (24), pp.11565-11575. ⟨10.1158/0008-5472.can-07-2536⟩ Article dans une revue hal-03623830v1
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines C. Ginestier,J. Adelaiede,A. Goncalves,L. Repellini,F. Sircoulombet al. Oncogene, 2007, 26 (50), pp.7163-7169. ⟨10.1038/sj.onc.1210528⟩ Article dans une revue hal-01431967v1
Towards an integrated cellular and molecular: definition of breast cancers Emmanuelle Charafe-Jauffret,Max Chaffanet,François Bertucci,Christophe Ginestier,Jocelyne Jacquemieret al. Médecine/Sciences, 2007, 23 (6-7), pp.626-632. ⟨10.1051/medsci/20072367626⟩ Article dans une revue hal-01431964v1
Breast cancer genomics: real-time use François Bertucci,Daniel Birnbaum Lancet Oncology, 2007, 8 (12), pp.1045-1047. ⟨10.1016/s1470-2045(07)70350-9⟩ Article dans une revue istex hal-03623829v1
Desmoid-Type Fibromatosis François Bertucci,Anthony Gonçalves,Patrice Viens,Genevieve Monges,Patrice Dubreuil Journal of Neurosurgery, 2007, 107 (2), pp.473-475. ⟨10.3171/jns-07/08/0473⟩ Article dans une revue hal-03623832v1
Lung cancer in elderly patients: A retrospective analysis of practice in a single institution Anne Madroszyk-Flandin,Sophie Bagattini,Anthony Gonçalves,Naji Salem,Frédéric Viretet al. Critical Reviews in Oncology/Hematology, 2007, 64 (1), pp.43-48. ⟨10.1016/j.critrevonc.2007.06.009⟩ Article dans une revue istex hal-03623831v1
A Gene Signature in Breast Cancer François Bertucci New England Journal of Medicine, 2007, 356 (18), pp.1887-1888. ⟨10.1056/nejmc070393⟩ Article dans une revue hal-03623833v1
Comparison of Induced Sputum and Bronchoalveolar Lavage in Lung Transplant Recipients François Bertucci,Pascal Finetti,Nathalie Cervera,Emmanuelle Charafe-Jauffret,José Adélaïdeet al. The Journal of Heart and Lung Transplantation, 2006, 25 (5), pp.523-532. ⟨10.1016/j.healun.2005.12.009⟩ Article dans une revue hal-03583497v1
FGFR1 and WT1 are markers of human prostate cancer progression. Elizabeth Devilard,Franck Bladou,Olivier Ramuz,Gilles Karsenty,Jean-Philippe Dalèset al. BMC Cancer, 2006, 6, pp.272. ⟨10.1186/1471-2407-6-272⟩ Article dans une revue inserm-00121110v1
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas B Ballester,O Ramuz,C Gisselbrecht,G Doucet,L Loiet al. Oncogene, 2006, 25 (10), pp.1560-1570. ⟨10.1038/sj.onc.1209178⟩ Article dans une revue hal-01612147v1
Response of a KIT-Positive Extra-Abdominal Fibromatosis to Imatinib Mesylate and KIT Genetic Analysis Anthony Gonçalves,Genevieve Monges,Ying Yang,Fabienne Palmerini,Patrice Dubreuilet al. JNCI: Journal of the National Cancer Institute, 2006, 98 (8), pp.562-563. ⟨10.1093/jnci/djj137⟩ Article dans une revue hal-03623835v1
Identification des facteurs génétiques associés à l'évolution des cancers coliques Sylviane Olschwang,Frédéric Viret,Geneviève Monges,Jean-François Seitz,Nicolas Sevenetet al. Médecine/Sciences, 2006, 22, pp.45-49. ⟨10.1051/medsci/2006221s45⟩ Article dans une revue hal-03623837v1
Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers François Bertucci,Pascal Finetti,Nathalie Cervera,Emmanuelle Charafe-Jauffret,Emilie Mamessieret al. Cancer Research, 2006, 66 (9), pp.4636-4644. ⟨10.1158/0008-5472.CAN-06-0031⟩ Article dans une revue hal-03606415v1
Proteomics of Breast Cancer François Bertucci,Daniel Birnbaum,Anthony Goncalves Molecular and Cellular Proteomics, 2006, 5 (10), pp.1772-1786. ⟨10.1074/mcp.r600011-mcp200⟩ Article dans une revue hal-03623834v1
Gene expression profiling of breast cell lines identifies potential new basal markers E Charafe-Jauffret,C Ginestier,F Monville,P Finetti,José Adelaïdeet al. Oncogene, 2006, 25 (15), pp.2273-2284. ⟨10.1038/sj.onc.1209254⟩ Article dans une revue hal-01431970v1
Prognosis and gene expression profiling of 20q13-amplified breast cancers Christophe Ginestier,Nathalie Cervera,Pascal Finetti,Sverine Esteyries,Benjamin Esterniet al. Clinical Cancer Research, 2006, 12 (15), pp.4533-4544. ⟨10.1158/1078-0432.CCR-05-2339⟩ Article dans une revue hal-01431971v1
Gene Expression Profiling and Clinical Outcome in Breast Cancer François Bertucci,Pascal Finetti,Nathalie Cervera,Dominique Maraninchi,Patrice Vienset al. OMICS, 2006, 10 (4), pp.429-443. ⟨10.1089/omi.2006.10.429⟩ Article dans une revue hal-03623836v1
Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer François Bertucci,Pascal Finetti,Jacques Rougemont,Emmanuelle Charafe-Jauffret,Nathalie Cerveraet al. Cancer Research, 2005, 65 (6), pp.2170-2178. ⟨10.1158/0008-5472.can-04-4115⟩ Article dans une revue hal-03623838v1
Comprehensive profiling of 8p11-12 amplification in breast cancer. Véronique Gelsi-Boyer,Béatrice Orsetti,Nathalie Cervera,Pascal Finetti,Fabrice Sircoulombet al. Molecular Cancer Research, 2005, 3 (12), pp.655-67. ⟨10.1158/1541-7786.MCR-05-0128⟩ Article dans une revue inserm-00158812v1
Immunophenotypic analysis of inflammatory breast cancers: identification of an‘inflammatory signature’ Emmanuelle Charafe-Jauffret,Carole Tarpin,Valérie-Jeanne Bardou,François Bertucci,Christophe Ginestieret al. Journal of Pathology, 2004, 202 (3), pp.265-273. ⟨10.1002/path.1515⟩ Article dans une revue istex hal-03623843v1
Feature extraction and signal processing for nylon DNA microarrays. Fabrice Lopez,Jacques Rougemont,Béatrice Loriod,Aude Bourgeois,Laurence Loïet al. BMC Genomics, 2004, 5 (1), pp.38. ⟨10.1186/1471-2164-5-38⟩ Article dans une revue inserm-00112016v1
Gene expression profiling of thyroid mitochondria rich tumours reveals a coordinated up-regulation of genes involved in oxidative metabolism O Baris,F Savagner,V Nasser,Béatrice B. Loriod,S Granjeaudet al. Biochimica biophysica acta (BBA) - Bioenergetics, 2004, 1657, pp.84-85 Article dans une revue hal-01612149v1
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters F Bertucci,S Salas,S Eysteries,V Nasser,P Finettiet al. Oncogene, 2004, 23 (7), pp.1377-1391. ⟨10.1038/sj.onc.1207262⟩ Article dans une revue hal-01612151v1
Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis C Thieblemont,V Nasser,P Felman,K Leroy,S Gazzoet al. Blood, 2004, 103 (7), pp.2727-2737. ⟨10.1182/blood-2003-06-2160⟩ Article dans une revue hal-01612152v1
Identification and validation of an ERBB2 gene expression signature in breast cancers François Bertucci,Nathalie Borie,Christophe Ginestier,Agnès Groulet,Emmanuelle Charafe-Jauffretet al. Oncogene, 2004, 23 (14), pp.2564-2575. ⟨10.1038/sj.onc.1207361⟩ Article dans une revue hal-03623842v1
Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling Norbert Vey,Marie-Joëlle Mozziconacci,Agnès Groulet-Martinec,Stéphane Debono,Pascal Finettiet al. Oncogene, 2004, 23 (58), pp.9381-9391. ⟨10.1038/sj.onc.1207910⟩ Article dans une revue hal-03623840v1
Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors O Baris,F Savagner,V Nasser,Béatrice B. Loriod,S Granjeaudet al. Journal of Clinical Endocrinology and Metabolism, 2004, 89 (2), pp.994-1005. ⟨10.1210/jc.2003-031238⟩ Article dans une revue hal-01612150v1
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy F Bertucci,P Finetti,J Rougemont,E Charafe-Jauffret,V Nasseret al. Cancer Research, 2004, 64 (23), pp.8558-8565. ⟨10.1158/0008-5472.CAN-04-2696⟩ Article dans une revue hal-01612154v1
Breast cancer revisited using DNA array-based gene expression profiling François Bertucci,Patrice Viens,Pascal Hingamp,Valery Nasser,Rémi Houlgatteet al. International Journal of Cancer, 2003, 103 (5), pp.565-571. ⟨10.1002/ijc.10867⟩ Article dans une revue hal-03623846v1
Gene expression profiling of breast carcinomas using Nylon DNA arrays F Bertucci,Béatrice B. Loriod,V Nasser,S Granjeaud,R Tagettet al. Comptes Rendus. Biologies, 2003, 326 (10-11), pp.1031-1039. ⟨10.1016/j.crvi.2003.09.010⟩ Article dans une revue istex hal-01612156v1
Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease F Magrangeas,V Nasser,H Avet-Loiseau,Béatrice B. Loriod,O Decauxet al. Blood, 2003, 101 (12), pp.4998-5006. ⟨10.1182/blood-2002-11-3385⟩ Article dans une revue hal-01612158v1
DNA Arrays in Clinical Oncology: Promises and Challenges François Bertucci,Patrice Viens,Rebecca Tagett,Catherine Nguyen,Rémi Houlgatteet al. Laboratory Investigation, 2003, 83 (3), pp.305-316. ⟨10.1097/01.lab.0000059936.28369.19⟩ Article dans une revue hal-03623845v1
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer Christophe Ginestier,Valérie-Jeanne Bardou,Cornel Popovici,Emmanuelle Charafe-Jauffret,François Bertucciet al. International Journal of Cancer, 2003, 107 (5), pp.854-862. ⟨10.1002/ijc.11462⟩ Article dans une revue hal-03623844v1
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens D. Genre,P. Viens,F. Bertucci,C Chabannon,G. Graviset al. Bone Marrow Transplantation, 2002, 29 (11), pp.881-886. ⟨10.1038/sj.bmt.1703556⟩ Article dans une revue inserm-03199676v1
Gene-expression profiling and identification of patients at high risk of breast cancer François Bertucci,François Eisinger,Rémi Houlgatte,Patrice Viens,Daniel Birnbaum The Lancet, 2002, 360 (9327), pp.173-174. ⟨10.1016/s0140-6736(02)09399-6⟩ Article dans une revue istex hal-03623850v1
Gene expression profiles of poor-prognosis primary breast cancer correlate with survival F Bertucci,V Nasser,S Granjeaud,F Eisinger,José Adelaïdeet al. Human Molecular Genetics, 2002, 11 (8), pp.863-872. ⟨10.1093/hmg/11.8.863⟩ Article dans une revue hal-01612162v1
Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor Markers Christophe Ginestier,Emmanuelle Charafe-Jauffret,François Bertucci,François Eisinger,Jeannine Geneixet al. American Journal of Pathology, 2002, 161 (4), pp.1223-1233. ⟨10.1016/s0002-9440(10)64399-4⟩ Article dans une revue hal-03623848v1
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease Elisabeth Devilard,François Bertucci,Pascal Trempat,Réda Bouabdallah,Béatrice B. Loriodet al. Oncogene, 2002, 21 (19), pp.3095-3102. ⟨10.1038/sj.onc.1205418⟩ Article dans une revue hal-01612161v1
Re: Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers François Bertucci,F. Eisinger,R. Tagett,H. Sobol,D. Birnbaum JNCI: Journal of the National Cancer Institute, 2002, 94 (19), pp.1506-1507. ⟨10.1093/jnci/94.19.1506⟩ Article dans une revue istex hal-03623849v1
Reciprocal translocations in breast tumor cell lines: Cloning of a t(3;20) that targets the FHIT gene C. Popovici,Céline Basset,F. Bertucci,A. Orsetti,J. Adelaideet al. Genes, Chromosomes & Cancer, 2002, 35 (3), pp.204--218. ⟨10.1002/gcc.10107⟩ Article dans une revue istex hal-02197538v1
Molecular typing of breast cancer: transcriptomics and DNA microarrays F Bertucci,R Houlgatte,C Nguyen,A Benziane,V Nasseret al. Bulletin du Cancer, 2001, 88 (3), pp.277-286 Article dans une revue hal-01612164v1
Gene expression profiling using nylon arrays of candidates genes F Bertucci,Béatrice B. Loriod,R Houlgatte,C Nguyen Journal of Neurochemistry, 2001, 78, pp.110 Article dans une revue hal-01612165v1
DNA arrays: technological aspects and applications F Bertucci,Béatrice B. Loriod,R Tagett,S Granjeaud,D Birnbaumet al. Bulletin du Cancer, 2001, 88 (3), pp.243-252 Article dans une revue hal-01612166v1
Gene expression profiling of primary breast carcinomas using arrays of candidate genes F Bertucci,R Houlgatte,A Benziane,S Granjeaud,José Adelaïdeet al. Human Molecular Genetics, 2000, 9 (20), pp.2981-2991. ⟨10.1093/hmg/9.20.2981⟩ Article dans une revue hal-01612167v1
Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples F Bertucci,K Bernard,Béatrice B. Loriod,Yi-Chung Chang,S Granjeaudet al. Human Molecular Genetics, 1999, 8 (9), pp.1715-1722. ⟨10.1093/hmg/8.9.1715⟩ Article dans une revue hal-01612169v1
Expression scanning of an array of growth control genes in human tumor cell lines F Bertucci,S van Hulst,K Bernard,Béatrice B. Loriod,S Granjeaudet al. Oncogene, 1999, 18 (26), pp.3905-3912. ⟨10.1038/sj.onc.1202731⟩ Article dans une revue hal-01612170v1
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancer Patrice Viens,Dominique Genre,Christel Protiere,Gwenaelle Gravis,François Bertucciet al. European Cytokine Network, 1998, 9 (1), pp.93-98 Article dans une revue inserm-04975072v1

Communication dans un congrès (1)

PROPAN: Bayesian dose-finding of propranolol combined with metronomic fixed-dose cyclophosphamide based on bivariate efficacy-tolerability outcomes in patients with locally advanced or metastatic angiosarcoma (LAMA): A phase I-II sequential trial by the French Sarcoma Group. Sebastien Salas,Christine Chevreau,Elisabeth Jouve,Nicolas Penel,Axel Le Cesneet al. American Society of Clinical Oncology (ASCO) Annual meeting 2025, May 2025, Chicago, United States. ⟨10.1200/JCO.2025.43.16_suppl.e23542⟩ Communication dans un congrès hal-05470756v1

Chapitre d'ouvrage (2)

Detection of Driver Protein Complexes in Breast Cancer Metastasis by Large-Scale Transcriptome–Interactome Integration Maxime Garcia,Pascal Finetti,François Bertucci,Daniel Birnbaum,Ghislain Bidaut Gene Function Analysis, 1101, Humana Press, pp.67-85, 2014, Methods in Molecular Biology, ⟨10.1007/978-1-62703-721-1_5⟩ Chapitre d'ouvrage hal-03623759v1
Prognosis of breast cancer and gene expression profiling using DNA arrays F Bertucci,R Houlgatte,S Granjeaud,V Nasser,Béatrice B. Loriodet al. Microarrays, Immune Responses and Vaccines, 975, pp.217-231, 2002, 0077-8923;1-57331-446-3. ⟨10.1111/j.1749-6632.2002.tb05954.x⟩ Chapitre d'ouvrage istex hal-01612160v1

Pré-publication, Document de travail (5)

Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers Célestin BIGARRÉ,François Bertucci,Pascal Finetti,Gaëtan Macgrogan,Xavier Muraccioleet al. 2022 Pré-publication, Document de travail hal-03936594v1
Conditional activation of immune-related signatures and prognostic significance: a pan-cancer analysis Jessica Roelands,Wouter Hendrickx,Raghvendra Mall,Mohamad Saad,Kyle Halliwillet al. 2022 Pré-publication, Document de travail hal-03623694v1
Loss of cyclin A2 in murine colonic epithelial cells disrupts colon homeostasis by triggering DNA damage and dysplasia and high cyclin A2 expression is a good-prognosis factor in patients with colorectal cancer Yuchen Guo,Monica Gabola,Rossano Lattanzio,Conception Paul,Valérie Pinetet al. 2022 Pré-publication, Document de travail hal-03623690v1
Epithelial-to-mesenchymal transition lowers the cholesterol pathway, which influences colon tumors differentiation Anaïs Aulas,Maria Lucia Liberatoscioli,Pascal Finetti,Olivier Cabaud,David Birnbaumet al. 2022 Pré-publication, Document de travail hal-03623627v1
The serine/threonine kinase MINK1 directly regulates the function of promigratory proteins Avais Daulat,Mônica Wagner,Stéphane Audebert,Malgorzata Kowalczewska,Jeremy Ariey-Bonnetet al. 2022 Pré-publication, Document de travail hal-03623628v1